Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
chr1	3542442	3542442	A	G	exonic	TPRG1L	.	synonymous SNV	TPRG1L:NM_182752:exon3:c.A459G:p.K153K	0.002845285	0.803826308	0.193328407	.	0.15732	0.10917	-0.117432389	44.89266336	7.9088	0.2904	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	42	chr1	3542442	chr1:3542442	A	G	51	PASS	AN=2;DP=42	GT	0/1
chr1	31838651	31838651	C	A	UTR3	FABP3	NM_001320996:c.*82G>T;NM_004102:c.*82G>T	.	.	0.354913337	0.591610018	0.053476645	.	0.1867	.	0.191216164	66.57230479	91.66803	2.05891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	chr1	31838651	chr1:31838651	C	A	.	PASS	AN=0;DP=32	GT	0/1
chr1	49202109	49202109	C	T	exonic	BEND5	.	nonsynonymous SNV	BEND5:NM_001349793:exon4:c.G403A:p.G135R,BEND5:NM_001302082:exon5:c.G403A:p.G135R,BEND5:NM_024603:exon5:c.G910A:p.G304R,BEND5:NM_001349794:exon6:c.G403A:p.G135R,BEND5:NM_001349795:exon7:c.G655A:p.G219R	0.114990689	0.857716612	0.027292699	.	0.62579	0.11262	-0.271755481	34.31823543	38.21221	1.13413	0.002	0.721	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	1.245	0.315	L	.	.	.	-4.7	0.798	D	0.92	0.911	-0.708	0.601	T	0.236	0.603	T	0.017	0.385	T	7.505	0.952	34	0.999	0.990	0.957	0.654	D	c	0.521	0.574	1.000	0.747	0.706	0.609	0	5.35	0.762	5.787	0.684	0.935	0.490	1.000	0.715	1.000	0.888	18.038	0.892	BEN domain	.	.	0.5	.	26	chr1	49202109	chr1:49202109	C	T	.	PASS	AN=0;DP=26	GT	0/1
chr1	53351594	53351594	-	T	intronic	ZYG11A	.	.	.	.	.	.	.	0.11936	.	0.837848571	88.22835574	323.85912	3.82518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	83	chr1	53351594	chr1:53351594	C	CT	59	PASS	AN=2;DP=83	GT	0/1
chr1	62189460	62189460	-	A	intronic	TM2D1	.	.	.	0.042061483	0.929476013	0.028462504	.	0.34406	0.09894	.	.	115.6404	2.33925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.77	37	chr1	62189460	chr1:62189460	T	TA	14.77	PASS	AN=0;DP=37	GT	0/1
chr1	65211089	65211089	G	A	exonic	RAVER2	.	synonymous SNV	RAVER2:NM_018211:exon1:c.G234A:p.Q78Q	1.86E-06	0.968062953	0.031935187	.	0.16139	0.09116	-0.113792788	45.25831564	48.72242	1.36171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	162	chr1	65211089	chr1:65211089	G	A	98	PASS	AN=2;DP=162	GT	0/1
chr1	74575212	74575212	-	T	exonic	LRRIQ3	.	frameshift insertion	LRRIQ3:NM_001105659:exon5:c.732dupA:p.Q245Tfs*6,LRRIQ3:NM_001322315:exon5:c.732dupA:p.Q245Tfs*6	3.22E-15	0.005170825	0.994829175	.	0.06919	.	1.379742765	94.60368011	1020.69778	6.14814	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	26	chr1	74575212	chr1:74575212	G	GT	51	PASS	AN=2;DP=26	GT	0/1
chr1	74818936	74818936	-	T	intronic	FPGT-TNNI3K;TNNI3K	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	35	chr1	74818936	chr1:74818936	G	GT	65	PASS	AN=2;DP=35	GT	0/1
chr1	114025434	114025434	-	T	intronic	MAGI3	.	.	.	0.570580157	0.429419836	7.05E-09	.	0.93064	0.10933	-0.925889687	9.754659118	136.27247	2.53739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	49	chr1	114025434	chr1:114025434	C	CT	71	PASS	AN=2;DP=49	GT	0/1
chr1	115276990	115276990	C	A	intronic	CSDE1	.	.	.	0.999951564	4.84E-05	1.34E-12	.	0.71193	0.17821	-1.001120478	8.321538099	30.92563	0.97838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	42	chr1	115276990	chr1:115276990	C	A	39	PASS	AN=2;DP=42	GT	0/1
chr1	150297433	150297433	G	A	exonic	PRPF3	.	synonymous SNV	PRPF3:NM_004698:exon2:c.G33A:p.L11L	0.999998844	1.16E-06	7.41E-16	DISEASE: Retinitis pigmentosa 18 (RP18) [MIM:601414]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:11773002, ECO:0000269|PubMed:12714658}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.83102	0.16844	-0.560178693	19.30879925	16.61976	0.58582	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	chr1	150297433	chr1:150297433	G	A	.	PASS	AN=0;DP=30	GT	0/1
chr1	153658184	153658184	G	A	intronic	NPR1	.	.	.	0.000172509	0.999775772	5.17E-05	.	0.25987	0.31819	-0.238793231	36.3116301	1510.90255	7.21833	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	chr1	153658184	chr1:153658184	G	A	.	PASS	AN=0;DP=44	GT	0/1
chr1	155152397	155152397	-	C	exonic	TRIM46	.	frameshift insertion	TRIM46:NM_001282378:exon7:c.1198dupC:p.A402Gfs*9,TRIM46:NM_001256599:exon8:c.1507dupC:p.A505Gfs*9,TRIM46:NM_001256601:exon8:c.1537dupC:p.A515Gfs*9,TRIM46:NM_001282379:exon8:c.1576dupC:p.A528Gfs*37,TRIM46:NM_025058:exon8:c.1576dupC:p.A528Gfs*9,TRIM46:NM_001256600:exon9:c.1450dupC:p.A486Gfs*9	0.998652125	0.00134787	4.43E-09	.	0.59864	0.14106	-0.843147538	11.2762444	131.25378	2.49537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	184	chr1	155152397	chr1:155152397	G	GC	90	PASS	AN=2;DP=184	GT	0/1
chr1	165664684	165664684	T	A	intronic	ALDH9A1	.	.	.	1.29E-05	0.953462413	0.046524673	.	0.04374	0.24685	-0.021969881	52.14673272	462.50185	4.4573	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	73	chr1	165664684	chr1:165664684	T	A	39	PASS	AN=2;DP=73	GT	0/1
chr1	174926956	174926956	G	T	intronic	RABGAP1L	.	.	.	0.089172714	0.910824162	3.12E-06	.	0.37939	.	-1.087493118	7.106628922	552.4126	4.7801	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	63	chr1	174926956	chr1:174926956	G	T	60	PASS	AN=2;DP=63	GT	0/1
chr1	213224717	213224719	GGT	-	UTR5	RPS6KC1	NM_012424:c.-30_-28del-;NM_001136138:c.-30_-28del-;NM_001287218:c.-78224_-78222del-;NM_001287219:c.-78224_-78222del-;NM_001287220:c.-189498_-189496del-;NM_001287221:c.-78224_-78222del-;NM_001349646:c.-30_-28del-;NM_001349647:c.-30_-28del-;NM_001349648:c.-78224_-78222del-;NM_001349649:c.-78224_-78222del-;NM_001349650:c.-78224_-78222del-;NM_001349651:c.-78224_-78222del-;NM_001349652:c.-78224_-78222del-;NM_001349653:c.-78224_-78222del-;NM_001349654:c.-78224_-78222del-;NM_001349657:c.-116540_-116538del-;NM_001349658:c.-116540_-116538del-;NM_001349659:c.-179135_-179133del-;NM_001349660:c.-179135_-179133del-;NM_001349661:c.-179135_-179133del-;NM_001349662:c.-179135_-179133del-;NM_001349663:c.-189498_-189496del-;NM_001349664:c.-189498_-189496del-;NM_001349665:c.-189498_-189496del-;NM_001349666:c.-189498_-189496del-;NM_001349667:c.-189498_-189496del-;NM_001349668:c.-189498_-189496del-;NM_001349669:c.-189498_-189496del-;NM_001349670:c.-189498_-189496del-;NM_001349671:c.-189498_-189496del-;NM_001349672:c.-189498_-189496del-	.	.	0.020440097	0.979528986	3.09E-05	.	0.12108	0.12186	0.450099045	78.01958009	426.82545	4.31586	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	36	chr1	213224716	chr1:213224716	GGGT	G	43	PASS	AN=2;DP=36	GT	0/1
chr1	237850715	237850715	C	T	intronic	RYR2	.	.	.	0.999999934	6.56E-08	1.25E-37	DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 2 (ARVD2) [MIM:600996]: A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias. {ECO:0000269|PubMed:11159936}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. {ECO:0000269|PubMed:11157710, ECO:0000269|PubMed:12093772, ECO:0000269|PubMed:12106942, ECO:0000269|PubMed:15046072, ECO:0000269|PubMed:15046073, ECO:0000269|PubMed:15466642, ECO:0000269|PubMed:15544015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.27314	0.27889	-5.869562633	0.053078556	1401.64962	6.99815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	254	chr1	237850715	chr1:237850715	C	T	71	PASS	AN=2;DP=254	GT	0/1
chr1	244595875	244595875	C	T	exonic	ADSS	.	synonymous SNV	ADSS:NM_001126:exon4:c.G378A:p.R126R	0.822870228	0.177095098	3.47E-05	.	0.71511	0.34803	0.014844891	54.94810097	99.3475	2.15777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	178	chr1	244595875	chr1:244595875	C	T	59	PASS	AN=2;DP=178	GT	0/1
chr2	33590558	33590558	C	T	exonic	LTBP1	.	synonymous SNV	LTBP1:NM_001166264:exon26:c.C3595T:p.L1199L,LTBP1:NM_001166266:exon26:c.C3436T:p.L1146L,LTBP1:NM_000627:exon27:c.C3721T:p.L1241L,LTBP1:NM_001166265:exon27:c.C3562T:p.L1188L,LTBP1:NM_206943:exon31:c.C4699T:p.L1567L	0.526234698	0.473765302	1.69E-11	.	0.4738	0.14744	-0.44293645	24.46921444	877.89035	5.77162	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	16	chr2	33590558	chr2:33590558	C	T	.	PASS	AN=0;DP=16	GT	0/1
chr2	38527398	38527399	CT	-	intronic	ATL2	.	.	.	0.980197371	0.019802499	1.30E-07	.	0.50505	0.11563	-0.067881249	48.69072895	3458.2471	11.29657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	23	chr2	38527397	chr2:38527397	ACT	A	54	PASS	AN=2;DP=23	GT	0/1
chr2	43980744	43980744	-	T	intronic	PLEKHH2	.	.	.	1.79E-26	0.030270259	0.969729741	.	0.12448	0.091	-0.823216783	11.68318	2775.67326	9.94659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	17	chr2	43980744	chr2:43980744	C	CT	41	PASS	AN=2;DP=17	GT	0/1
chr2	48807976	48807976	T	C	exonic	STON1;STON1-GTF2A1L	.	synonymous SNV	STON1-GTF2A1L:NM_001198594:exon1:c.T204C:p.D68D,STON1-GTF2A1L:NM_001198593:exon2:c.T204C:p.D68D,STON1:NM_006873:exon2:c.T204C:p.D68D,STON1-GTF2A1L:NM_172311:exon2:c.T204C:p.D68D,STON1:NM_001198595:exon3:c.T204C:p.D68D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	27	chr2	48807976	chr2:48807976	T	C	93	PASS	AN=2;DP=27	GT	0/1
chr2	66663051	66663051	C	T	intronic	MEIS1	.	.	.	0.990885197	0.009112474	2.33E-06	.	0.84073	0.23021	-0.317668748	31.45789101	129.87684	2.48316	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	chr2	66663051	chr2:66663051	C	T	.	PASS	AN=0;DP=53	GT	0/1
chr2	108490151	108490152	TG	-	intronic	RGPD4	.	.	.	.	.	.	.	.	.	.	.	3826.98843	12.16508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.59	40	chr2	108490150	chr2:108490150	ATG	A	12.59	PASS	AN=0;DP=40	GT	0/1
chr2	111644331	111644331	A	G	intronic	ACOXL	.	.	.	6.28E-10	0.400098611	0.599901388	.	0.07205	0.07959	1.86668643	97.19863175	3441.02377	11.26674	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	83	chr2	111644331	chr2:111644331	A	G	86	PASS	AN=2;DP=83	GT	0/1
chr2	113138347	113138347	G	A	intronic	RGPD5;RGPD8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	128	chr2	113138347	chr2:113138347	G	A	.	PASS	AN=0;DP=128	GT	0/1
chr2	119739162	119739162	A	-	intronic	MARCO	.	.	.	6.42E-08	0.872393291	0.127606645	.	0.064	0.24721	-0.374708069	28.15522529	845.48074	5.68855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	30	chr2	119739161	chr2:119739161	GA	G	43	PASS	AN=2;DP=30	GT	0/1
chr2	128647869	128647869	C	G	intergenic	AMMECR1L;SAP130	dist=4355;dist=50922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	33	chr2	128647869	chr2:128647869	C	G	59	PASS	AN=2;DP=33	GT	0/1
chr2	131459814	131459814	T	-	intergenic	CYP4F30P;GPR148	dist=16379;dist=26829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	52	chr2	131459813	chr2:131459813	CT	C	45	PASS	AN=2;DP=52	GT	0/1
chr2	138000119	138000119	C	T	exonic	THSD7B	.	nonsynonymous SNV	THSD7B:NM_001316349:exon10:c.C2243T:p.P748L	5.65E-06	0.999994327	1.97E-08	.	0.33549	0.08669	.	.	4772.07743	13.99787	0.047	0.403	D	0.949	0.518	P	0.756	0.544	P	0.000	0.629	D	0.999	0.810	D	1.665	0.427	L	2.16	0.192	T	-3.07	0.632	D	0.289	0.348	-1.103	0.037	T	0.103	0.381	T	0.011	0.274	T	5.488	0.745	26.2	0.987	0.449	0.322	0.243	N	c	0.239	0.226	0.000	0.056	0.638	0.428	0	4.87	0.627	0.408	0.206	0.935	0.490	0.107	0.227	0.911	0.388	17.396	0.873	.	.	.	0.5	41	69	chr2	138000119	chr2:138000119	C	T	41	PASS	AN=2;DP=69	GT	0/1
chr2	148602603	148602603	G	A	UTR5	ACVR2A	NM_001616:c.-119G>A	.	.	0.993932262	0.006067564	1.74E-07	.	0.69088	0.23984	-0.339715008	30.06605331	11.33135	0.40758	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	234	chr2	148602603	chr2:148602603	G	A	65	PASS	AN=2;DP=234	GT	0/1
chr2	152695190	152695191	TC	-	UTR3	CACNB4	NM_001320722:c.*443_*442delGA;NM_001145798:c.*443_*442delGA;NM_000726:c.*443_*442delGA;NM_001330115:c.*443_*442delGA;NM_001330116:c.*443_*442delGA;NM_001330114:c.*443_*442delGA;NM_001330113:c.*443_*442delGA;NM_001330117:c.*443_*442delGA;NM_001330118:c.*443_*442delGA;NM_001005747:c.*443_*442delGA;NM_001005746:c.*443_*442delGA	.	.	0.011363582	0.988273668	0.00036275	DISEASE: Juvenile myoclonic epilepsy 6 (EJM6) [MIM:607682]: A subtype of idiopathic generalized epilepsy. Patients have afebrile seizures only, with onset in adolescence (rather than in childhood) and myoclonic jerks which usually occur after awakening and are triggered by sleep deprivation and fatigue. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Episodic ataxia 5 (EA5) [MIM:613855]: A disorder characterized by episodes of vertigo and ataxia that last for several hours. Interictal examination show spontaneous downbeat and gaze-evoked nystagmus, mild dysarthria and truncal ataxia. {ECO:0000269|PubMed:10762541}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.19944	0.13941	0.082802743	60.09082331	22.57919	0.75555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	29	chr2	152695189	chr2:152695189	TTC	T	45	PASS	AN=2;DP=29	GT	0/1
chr2	160958350	160958351	AA	-	intronic	ITGB6	.	.	.	1.91E-15	0.02690241	0.97309759	DISEASE: Amelogenesis imperfecta 1H (AI1H) [MIM:616221]: A disorder characterized by defective enamel formation, resulting in hypoplastic and hypomineralized tooth enamel that may be rough, pitted, and/or discolored. {ECO:0000269|PubMed:24305999, ECO:0000269|PubMed:24319098}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.49818	0.25886	-0.593358137	18.22953527	250.787	3.41252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	14	chr2	160958349	chr2:160958349	GAA	G	78	PASS	AN=2;DP=14	GT	1/0
chr2	169984066	169984066	C	A	UTR3	LRP2	NM_004525:c.*1107G>T	.	.	1	1.49E-12	3.66E-46	.	0.64775	0.54233	3.324377969	99.4220335	2032.71856	8.29976	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	chr2	169984066	chr2:169984066	C	A	.	PASS	AN=0;DP=46	GT	0/1
chr2	172943939	172943939	-	T	intronic	METAP1D	.	.	.	1.56E-06	0.404676324	0.59532212	.	.	.	-0.093566408	46.7386176	1129.38456	6.41406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	20	chr2	172943939	chr2:172943939	G	GT	41	PASS	AN=2;DP=20	GT	0/1
chr2	198362018	198362018	T	C	exonic	HSPD1	.	synonymous SNV	HSPD1:NM_002156:exon3:c.A273G:p.K91K,HSPD1:NM_199440:exon3:c.A273G:p.K91K	0.985208244	0.01479021	1.55E-06	DISEASE: Spastic paraplegia 13, autosomal dominant (SPG13) [MIM:605280]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. {ECO:0000269|PubMed:11898127}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukodystrophy, hypomyelinating, 4 (HLD4) [MIM:612233]: A severe autosomal recessive hypomyelinating leukodystrophy. Clinically characterized by infantile-onset rotary nystagmus, progressive spastic paraplegia, neurologic regression, motor impairment, profound mental retardation. Death usually occurs within the first two decades of life. {ECO:0000269|PubMed:18571143}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.9786	0.9809	-0.203796826	38.81811748	89.54005	2.03508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	14	chr2	198362018	chr2:198362018	T	C	73	PASS	AN=2;DP=14	GT	0/1
chr2	208602115	208602115	-	T	intronic	CCNYL1	.	.	.	0.977770144	0.022209066	2.08E-05	.	0.62342	0.07638	-0.361761279	28.6329323	44.05929	1.26436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	25	chr2	208602115	chr2:208602115	A	AT	40	PASS	AN=2;DP=25	GT	0/1
chr2	231943397	231943397	C	T	exonic	PSMD1	.	nonsynonymous SNV	PSMD1:NM_001191037:exon10:c.C1096T:p.H366Y,PSMD1:NM_002807:exon10:c.C1096T:p.H366Y	0.999999203	7.97E-07	3.00E-16	.	0.94807	0.14977	-0.380166007	27.88393489	75.57454	1.81948	0.064	0.365	T	0.928	0.501	P	0.742	0.539	P	0.000	0.843	D	1	0.810	D	2.63	0.772	M	.	.	.	-5.5	0.858	D	0.959	0.957	0.009	0.824	D	0.486	0.804	T	0.052	0.651	D	4.542	0.608	24.3	0.998	0.897	0.994	0.952	D	c	0.811	0.803	1.000	0.747	0.707	0.730	0	5.68	0.880	7.841	0.850	0.800	0.324	1.000	0.715	0.995	0.604	19.784	0.964	.	.	.	0.5	.	29	chr2	231943397	chr2:231943397	C	T	.	PASS	AN=0;DP=29	GT	0/1
chr2	234669144	234669144	G	A	exonic	UGT1A1	.	nonsynonymous SNV	UGT1A1:NM_000463:exon1:c.G211A:p.G71R	2.94E-09	0.085606144	0.914393853	DISEASE: Gilbert syndrome (GILBS) [MIM:143500]: Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints. {ECO:0000269|PubMed:11013440, ECO:0000269|PubMed:12139570, ECO:0000269|PubMed:7715297, ECO:0000269|PubMed:9627603}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Transient familial neonatal hyperbilirubinemia (HBLRTFN) [MIM:237900]: A condition characterized by excessive concentration of bilirubin in the blood, which may lead to jaundice. Breast milk jaundice is a common problem in nursing infants. {ECO:0000269|PubMed:11061796}. Note=The disease may be caused by mutations affecting the gene represented in this entry. The defect has been ascribed to various breast milk substances, but the component or combination of components that is responsible remains unclear. Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk. One or more components in the milk may trigger the jaundice in infants who have such mutations. Mutations are identical to those detected in patients with Gilbert syndrome, a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia.; DISEASE: Crigler-Najjar syndrome 1 (CN1) [MIM:218800]: Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life. CN1 inheritance is autosomal recessive. {ECO:0000269|PubMed:11013440, ECO:0000269|PubMed:15712364, ECO:0000269|PubMed:1634050, ECO:0000269|PubMed:17229650, ECO:0000269|PubMed:19830808, ECO:0000269|PubMed:23992562, ECO:0000269|PubMed:7906695, ECO:0000269|PubMed:7989045, ECO:0000269|PubMed:7989595, ECO:0000269|PubMed:8226884}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Crigler-Najjar syndrome 2 (CN2) [MIM:606785]: Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage. Phenobarbital, which induces the partially deficient glucuronyl transferase, can diminish the jaundice. CN2 inheritance is autosomal dominant. {ECO:0000269|PubMed:11013440, ECO:0000269|PubMed:11370628, ECO:0000269|PubMed:12402338, ECO:0000269|PubMed:15712364, ECO:0000269|PubMed:17229650, ECO:0000269|PubMed:19830808, ECO:0000269|PubMed:23099197, ECO:0000269|PubMed:23992562, ECO:0000269|PubMed:7989595, ECO:0000269|PubMed:8276413, ECO:0000269|PubMed:8280139, ECO:0000269|PubMed:8706880, ECO:0000269|PubMed:9621515, ECO:0000269|PubMed:9639672}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.58091	-0.556537043	19.72753008	185.91297	2.96084	0.04	0.421	D	0.127	0.581	B	0.183	0.497	B	.	.	.	0.599	0.309	P	1.39	0.351	L	0.09	0.615	T	-1.77	0.486	N	0.097	0.100	-1.081	0.071	T	0.001	0.002	T	.	.	.	4.055	0.545	23.7	0.997	0.801	0.339	0.247	N	c	-0.077	-0.054	1.000	0.500	0.487	0.133	0	5.14	0.699	3.900	0.558	1.048	0.713	0.572	0.273	0.951	0.427	7.612	0.271	.	.	.	0.5	51	10	chr2	234669144	chr2:234669144	G	A	51	PASS	AN=2;DP=10	GT	0/1
chr3	25660094	25660094	-	T	intronic	TOP2B	.	.	.	0.997311093	0.002688907	1.64E-12	.	0.99834	0.37504	-0.150608082	42.28001887	748.55499	5.42826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	19	chr3	25660094	chr3:25660094	G	GT	75	PASS	AN=2;DP=19	GT	0/1
chr3	48228116	48228116	C	A	intronic	CDC25A	.	.	.	0.979698045	0.020301273	6.82E-07	.	0.99898	0.37326	-0.291981272	33.20358575	96.05413	2.11781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	chr3	48228116	chr3:48228116	C	A	.	PASS	AN=0;DP=27	GT	0/1
chr3	55052208	55052208	T	-	intronic	CACNA2D3	.	.	.	0.998032255	0.001967745	7.65E-13	.	0.66118	.	-0.837696902	11.45317292	106.33657	2.2377	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	38	chr3	55052207	chr3:55052207	CT	C	45	PASS	AN=2;DP=38	GT	0/1
chr3	154072393	154072393	G	A	intronic	GPR149	.	.	.	2.65E-05	0.763728348	0.236245188	.	0.15312	0.09679	-0.554717505	19.79830149	121.73084	2.40326	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	38	chr3	154072393	chr3:154072393	G	A	39	PASS	AN=2;DP=38	GT	0/1
chr3	156411797	156411797	G	T	intronic	TIPARP	.	.	.	0.99775209	0.002247834	7.62E-08	.	0.43821	0.12448	-0.66859065	15.76433121	52.4418	1.43246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	38	chr3	156411797	chr3:156411797	G	T	66	PASS	AN=2;DP=38	GT	0/1
chr3	180326488	180326488	G	C	splicing	TTC14	NM_001288582:exon11:c.1291-1G>C;NM_133462:exon11:c.1291-1G>C	.	.	4.42E-06	0.955823688	0.044171893	.	0.10216	0.1043	-0.020150552	52.25288983	125.31545	2.43621	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.409	0.590	24.1	0.995	0.675	0.998	0.995	D	c	1.224	1.087	1.000	0.747	0.295	0.044	0	5.64	0.864	8.519	0.903	1.048	0.713	1.000	0.715	1.000	0.888	19.701	0.960	.	.	.	0.5	75	40	chr3	180326488	chr3:180326488	G	C	75	PASS	AN=2;DP=40	GT	0/1
chr3	183665257	183665257	A	-	exonic	ABCC5	.	frameshift deletion	ABCC5:NM_001320032:exon23:c.1853delT:p.L618Cfs*24,ABCC5:NM_005688:exon23:c.3269delT:p.L1090Cfs*24	0.896205135	0.103794865	2.35E-11	.	0.38723	0.35905	-1.967739992	1.816466148	80.81009	1.89955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	33	chr3	183665256	chr3:183665256	CA	C	45	PASS	AN=2;DP=33	GT	0/1
chr4	184267	184268	GT	-	intergenic	ZNF718;ZNF876P	dist=26318;dist=22121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.23	31	chr4	184266	chr4:184266	AGT	A	13.23	PASS	AN=0;DP=31	GT	0/1
chr4	1929514	1929514	T	A	intronic	NSD2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	77	chr4	1929514	chr4:1929514	T	A	39	PASS	AN=2;DP=77	GT	0/1
chr4	4864404	4864404	-	T	intronic	MSX1	.	.	.	0.275361731	0.633641369	0.090996899	DISEASE: Tooth agenesis selective 1 (STHAG1) [MIM:106600]: A form of selective tooth agenesis, a common anomaly characterized by the congenital absence of one or more teeth. Selective tooth agenesis without associated systemic disorders has sometimes been divided into 2 types: oligodontia, defined as agenesis of 6 or more permanent teeth, and hypodontia, defined as agenesis of less than 6 teeth. The number in both cases does not include absence of third molars (wisdom teeth). Tooth agenesis selective type 1 can be associated with orofacial cleft in some patients. {ECO:0000269|PubMed:12097313, ECO:0000269|PubMed:8696335}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=MSX1 is deleted in some patients with Wolf- Hirschhorn syndrome (WHS). WHS results from sub-telomeric deletions in the short arm of chromosome 4. {ECO:0000305|PubMed:1969845}.; DISEASE: Ectodermal dysplasia 3, Witkop type (ECTD3) [MIM:189500]: A form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures such as hair, teeth, nails and sweat glands, with or without any additional clinical sign. Each combination of clinical features represents a different type of ectodermal dysplasia. ECTD3 is characterized by abnormalities largely limited largely to teeth (some of which are missing) and nails (which are poorly formed early in life, especially toenails). This condition is distinguished from anhidrotic ectodermal dysplasia by autosomal dominant inheritance and little involvement of hair and sweat glands. The teeth are not as severely affected. {ECO:0000269|PubMed:11369996}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Non-syndromic orofacial cleft 5 (OFC5) [MIM:608874]: A birth defect consisting of cleft lips with or without cleft palate. Cleft lips are associated with cleft palate in two-third of cases. A cleft lip can occur on one or both sides and range in severity from a simple notch in the upper lip to a complete opening in the lip extending into the floor of the nostril and involving the upper gum. {ECO:0000269|PubMed:12807959}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.83114	0.60631	.	.	590.93175	4.92812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	19	chr4	4864404	chr4:4864404	C	CT	40	PASS	AN=2;DP=19	GT	0/1
chr4	13628028	13628028	C	G	intronic	BOD1L1	.	.	.	0.999528154	0.000471846	4.77E-15	.	0.44566	0.08925	-0.63057096	16.79051663	1099.59021	6.34651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	252	chr4	13628028	chr4:13628028	C	G	76	PASS	AN=2;DP=252	GT	0/1
chr4	68443006	68443006	-	T	intronic	STAP1	.	.	.	0.00012955	0.846504647	0.153365802	.	0.66261	0.0976	-0.582225231	18.44184949	42.83661	1.24007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	14	chr4	68443006	chr4:68443006	C	CT	40	PASS	AN=2;DP=14	GT	0/1
chr4	73957836	73957836	T	C	exonic	ANKRD17	.	nonsynonymous SNV	ANKRD17:NM_198889:exon28:c.A4756G:p.M1586V,ANKRD17:NM_001286771:exon29:c.A5170G:p.M1724V,ANKRD17:NM_015574:exon29:c.A5506G:p.M1836V,ANKRD17:NM_032217:exon29:c.A5509G:p.M1837V	1	3.51E-10	8.18E-26	.	0.30304	.	-2.938435282	0.548478415	117.58974	2.35717	0.585	0.059	T	0.0	0.026	B	0.0	0.013	B	0.000	0.537	D	0.789	0.306	N	-0.255	0.038	N	-0.06	0.636	T	-0.44	0.146	N	0.075	0.178	-1.017	0.246	T	0.074	0.298	T	0.003	0.073	T	-1.162	0.026	0.008	0.521	0.046	0.677	0.332	D	c	-0.582	-0.345	0.999	0.372	0.707	0.730	0	3.85	0.434	2.018	0.404	0.112	0.206	1.000	0.715	1.000	0.888	5.386	0.154	K Homology domain	.	.	0.5	62	47	chr4	73957836	chr4:73957836	T	C	62	PASS	AN=2;DP=47	GT	0/1
chr4	76583936	76583936	-	A	intronic	G3BP2	.	.	.	0.983145417	0.016854151	4.31E-07	.	0.96341	0.18404	-0.317668748	31.45789101	27.08786	0.87395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	47	chr4	76583936	chr4:76583936	G	GA	50	PASS	AN=2;DP=47	GT	0/1
chr4	77116932	77116932	T	C	exonic	SCARB2	.	nonsynonymous SNV	SCARB2:NM_001204255:exon2:c.A203G:p.N68S,SCARB2:NM_005506:exon2:c.A203G:p.N68S	0.072442869	0.927026675	0.000530456	DISEASE: Epilepsy, progressive myoclonic 4, with or without renal failure (EPM4) [MIM:254900]: An autosomal recessive progressive myoclonic epilepsy associated with renal failure in some cases. Cognitive function is preserved. Myoclonus is a brief, involuntary twitching of a muscle or a group of muscles. {ECO:0000269|PubMed:18308289, ECO:0000269|PubMed:18424452, ECO:0000269|PubMed:19454373, ECO:0000269|PubMed:21670406}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Genetic variants in SCARB2 can act as modifier of the phenotypic expression and severity of Gaucher disease. {ECO:0000269|PubMed:21796727}.; 	0.2098	0.44672	0.485092724	79.37603208	107.27576	2.24626	0.008	0.586	D	0.999	0.899	D	0.996	0.916	D	0.000	0.843	D	1	0.810	D	3.23	0.897	M	-1.5	0.813	D	-3.98	0.737	D	0.438	0.515	0.631	0.923	D	0.724	0.905	D	0.178	0.854	D	5.247	0.709	25.6	0.999	0.959	0.963	0.683	D	c	0.871	0.812	1.000	0.747	0.706	0.609	0	5.55	0.832	7.674	0.830	0.113	0.207	1.000	0.715	0.996	0.625	14.673	0.684	.	.	.	0.5	51	61	chr4	77116932	chr4:77116932	T	C	51	PASS	AN=2;DP=61	GT	0/1
chr4	77969239	77969239	-	T	UTR3	CCNI	NM_001348133:c.*132_*133insA;NM_001348132:c.*132_*133insA;NM_001348134:c.*132_*133insA;NM_001348135:c.*132_*133insA;NM_001348136:c.*132_*133insA;NM_001348137:c.*132_*133insA;NM_001348138:c.*132_*133insA;NM_001348139:c.*132_*133insA;NM_001348140:c.*557_*558insA;NM_006835:c.*132_*133insA	.	.	0.789094043	0.209550825	0.001355133	.	0.26347	0.16383	0.104848986	61.49445624	48.69159	1.3608	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	26	chr4	77969239	chr4:77969239	A	AT	51	PASS	AN=2;DP=26	GT	0/1
chr4	86396749	86396749	C	G	intronic	ARHGAP24	.	.	.	0.004696081	0.995038485	0.000265435	.	0.39284	0.12435	-0.617221851	17.44515216	242.67907	3.36262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	66	chr4	86396749	chr4:86396749	C	G	66	PASS	AN=2;DP=66	GT	0/1
chr4	178243570	178243571	TG	-	intronic	NEIL3	.	.	.	3.55E-07	0.556963409	0.443036236	.	0.04798	0.07588	2.157029472	98.01250295	2050.68609	8.34807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	29	chr4	178243569	chr4:178243569	TTG	T	41	PASS	AN=2;DP=29	GT	0/1
chr4	184174907	184174909	TAG	-	splicing	WWC2	.	.	.	2.48E-05	0.99913924	0.000835949	.	0.47147	0.09503	0.055085661	57.54895022	2659.69867	9.69726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.77	19	chr4	184174906	chr4:184174906	TTAG	T	14.77	PASS	AN=0;DP=19	GT	0/1
chr5	14601134	14601134	G	A	exonic	FAM105A	.	nonsynonymous SNV	FAM105A:NM_019018:exon2:c.G125A:p.R42K	2.33E-07	0.275709326	0.724290442	.	0.1028	0.09828	0.106667882	61.73036093	389.06175	4.15395	0.055	0.384	T	0.167	0.270	B	0.085	0.279	B	0.019	0.273	N	1.000	0.090	N	2.34	0.674	M	2.26	0.176	T	-0.73	0.206	N	0.156	0.186	-1.030	0.203	T	0.030	0.131	T	0.008	0.209	T	0.917	0.182	10.18	0.942	0.238	0.335	0.246	N	c	-0.535	-0.504	1.000	0.436	0.706	0.609	0	2.64	0.304	1.228	0.320	0.143	0.228	0.854	0.303	0.135	0.201	7.490	0.265	.	.	.	0.5	.	35	chr5	14601134	chr5:14601134	G	A	.	PASS	AN=0;DP=35	GT	0/1
chr5	31435975	31435975	-	A	intronic	DROSHA	.	.	.	0.996399648	0.003600352	2.77E-14	.	0.60911	0.25509	-0.461076406	23.66124086	2101.94263	8.44322	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	19.54	29	chr5	31435975	chr5:31435975	C	CA	19.54	PASS	AN=0;DP=29	GT	0/1
chr5	33546166	33546166	G	A	exonic	ADAMTS12	.	synonymous SNV	ADAMTS12:NM_001324512:exon20:c.C4189T:p.L1397L,ADAMTS12:NM_030955:exon22:c.C4444T:p.L1482L	1.54E-11	0.999347073	0.000652927	.	0.10893	0.12072	0.865222355	88.74734607	1284.68357	6.74639	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	73	chr5	33546166	chr5:33546166	G	A	67	PASS	AN=2;DP=73	GT	0/1
chr5	67595055	67595055	A	-	UTR3	PIK3R1	NM_181523:c.*1626delA;NM_181524:c.*1626delA;NM_181504:c.*1626delA;NM_001242466:c.*1626delA	.	.	0.998240488	0.001759512	7.03E-11	DISEASE: Agammaglobulinemia 7, autosomal recessive (AGM7) [MIM:615214]: A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. {ECO:0000269|PubMed:22351933}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: SHORT syndrome (SHORTS) [MIM:269880]: A rare, multisystem disease characterized by short stature, anomalies of the anterior chamber of the eye, characteristic facial features such as triangular facies, lack of facial fat, and hypoplastic nasal alae with overhanging columella, partial lipodystrophy, hernias, hyperextensibility, and delayed dentition. The clinical phenotype can include insulin resistance, nephrocalcinosis, and hearing deficits. Developmental milestones and cognition are normal. {ECO:0000269|PubMed:23810378, ECO:0000269|PubMed:23810379, ECO:0000269|PubMed:23810382}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Immunodeficiency 36 (IMD36) [MIM:616005]: A primary immunodeficiency characterized by impaired B-cell function, hypogammaglobulinemia and recurrent infections. {ECO:0000269|PubMed:25133428}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.88821	0.86719	-0.756778259	13.44656759	2135.01489	8.50101	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	26	chr5	67595054	chr5:67595054	GA	G	42	PASS	AN=2;DP=26	GT	0/1
chr5	80504281	80504281	C	T	ncRNA_intronic	RNU5D-1;RNU5E-1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	76	chr5	80504281	chr5:80504281	C	T	.	PASS	AN=0;DP=76	GT	0/1
chr5	86629061	86629061	-	T	intronic	RASA1	.	.	.	0.999998286	1.71E-06	7.92E-17	DISEASE: Note=Mutations in the SH2 domain of RASA seem to be oncogenic and cause basal cell carcinomas.; DISEASE: Capillary malformation-arteriovenous malformation (CMAVM) [MIM:608354]: A disorder characterized by atypical capillary malformations that are multiple, small, round to oval in shape and pinkish red in color. These capillary malformations are associated with either arteriovenous malformation, arteriovenous fistula, or Parkes Weber syndrome. {ECO:0000269|PubMed:14639529, ECO:0000269|PubMed:24038909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Parkes Weber syndrome (PKWS) [MIM:608355]: Disorder characterized by a cutaneous flush with underlying multiple micro- arteriovenous fistulas, in association with soft tissue and skeletal hypertrophy of the affected limb. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.71615	0.1353	-0.821100135	11.88369899	144.431	2.61738	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	16	chr5	86629061	chr5:86629061	C	CT	51	PASS	AN=2;DP=16	GT	0/1
chr5	108516618	108516618	-	T	intronic	FER	.	.	.	0.968420467	0.031579516	1.69E-08	.	0.10446	0.1442	-0.440847477	24.59896202	528.33339	4.69026	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	14	chr5	108516618	chr5:108516618	A	AT	50	PASS	AN=2;DP=14	GT	0/1
chr5	133948395	133948396	CC	-	exonic	SAR1B	.	frameshift deletion	SAR1B:NM_016103:exon4:c.229_230del:p.G77Wfs*38,SAR1B:NM_001033503:exon5:c.229_230del:p.G77Wfs*38	0.006300416	0.910141255	0.083558329	.	0.4566	0.14201	-0.229483771	36.86010852	11.40907	0.41222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	411	chr5	133948394	chr5:133948394	ACC	A	73	PASS	AN=2;DP=411	GT	0/1
chr5	134194789	134194789	-	A	UTR3	C5orf24	NM_152409:c.*3632_*3633insA;NM_001300894:c.*1702_*1703insA;NM_001135586:c.*3632_*3633insA	.	.	0.640813736	0.331572836	0.027613428	.	0.34193	.	0.058937498	58.26256192	19.20533	0.66119	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.36	41	chr5	134194789	chr5:134194789	G	GA	10.36	PASS	AN=0;DP=41	GT	0/1
chr5	139227249	139227249	-	T	UTR3	NRG2	NM_001184935:c.*252_*253insA;NM_004883:c.*252_*253insA;NM_013981:c.*252_*253insA;NM_013982:c.*252_*253insA;NM_013983:c.*252_*253insA	.	.	0.995154288	0.004845611	1.01E-07	.	0.87096	0.14813	.	.	357.16396	4.00512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	44	chr5	139227249	chr5:139227249	C	CT	58	PASS	AN=2;DP=44	GT	0/1
chr5	177987759	177987759	A	-	intronic	COL23A1	.	.	.	9.57E-10	0.90264393	0.097356069	.	0.07258	0.08141	0.75875178	86.82472281	1444.11081	7.08807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	46	chr5	177987758	chr5:177987758	GA	G	68	PASS	AN=2;DP=46	GT	0/1
chr6	26422353	26422353	C	T	ncRNA_exonic	BTN2A3P	.	.	.	.	.	.	.	0.08337	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	160	chr6	26422353	chr6:26422353	C	T	.	PASS	AN=0;DP=160	GT	0/1
chr6	48036386	48036386	G	T	exonic	PTCHD4	.	stopgain	PTCHD4:NM_001013732:exon1:c.C6A:p.C2X,PTCHD4:NM_207499:exon1:c.C6A:p.C2X	0.002760598	0.98371978	0.013519622	.	0.76784	.	-0.707227564	14.71455532	97.49459	2.13448	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.214	0.966	36	0.991	0.512	0.969	0.713	D	c	1.008	0.822	1.000	0.747	0.549	0.223	0	4.19	0.485	6.906	0.754	0.945	0.533	1.000	0.715	1.000	0.888	16.577	0.845	.	.	.	0.5	59	203	chr6	48036386	chr6:48036386	G	T	59	PASS	AN=2;DP=203	GT	0/1
chr6	75966506	75966506	T	C	intronic	TMEM30A	.	.	.	0.040683085	0.952897895	0.00641902	.	0.2106	0.13393	-0.271755481	34.31823543	18.76838	0.64828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	24	chr6	75966506	chr6:75966506	T	C	85	PASS	AN=2;DP=24	GT	0/1
chr6	150052786	150052786	G	A	exonic	NUP43	.	synonymous SNV	NUP43:NM_198887:exon7:c.C876T:p.S292S	3.54E-06	0.803512486	0.196483972	.	0.48504	.	-0.381986487	27.68931352	249.75864	3.40424	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	60	chr6	150052786	chr6:150052786	G	A	60	PASS	AN=2;DP=60	GT	0/1
chr6	158923222	158923222	G	A	exonic	TULP4	.	nonsynonymous SNV	TULP4:NM_020245:exon13:c.G2527A:p.A843T	0.999936803	6.32E-05	5.19E-13	.	0.23566	.	-2.528819961	0.896437839	581.49333	4.88756	0.074	0.346	T	1.0	0.899	D	0.99	0.774	D	0.000	0.629	D	1.000	0.810	D	1.655	0.426	L	-0.28	0.676	T	-0.52	0.162	N	0.592	0.619	-0.263	0.760	T	0.394	0.748	T	0.210	0.873	D	1.613	0.255	13.92	0.997	0.839	0.984	0.822	D	c	0.417	0.308	1.000	0.747	0.646	0.450	0	5.07	0.680	4.960	0.631	1.045	0.669	1.000	0.715	0.685	0.306	18.087	0.893	.	.	.	0.5	.	34	chr6	158923222	chr6:158923222	G	A	.	PASS	AN=0;DP=34	GT	0/1
chr6	168323593	168323593	A	-	exonic	AFDN	.	frameshift deletion	AFDN:NM_001207008:exon20:c.2897delA:p.G967Vfs*18,AFDN:NM_001040000:exon21:c.2945delA:p.G983Vfs*17,AFDN:NM_001291964:exon21:c.2822delA:p.G942Vfs*18	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.41	28	chr6	168323592	chr6:168323592	GA	G	12.41	PASS	AN=0;DP=28	GT	0/1
chr7	27236537	27236537	C	T	UTR3	HOXA13	NM_000522:c.*1280G>A	.	.	.	.	.	DISEASE: Hand-foot-genital syndrome (HFG) [MIM:140000]: A disorder characterized by limb and genitourinary anomalies. Clinical features include small feet with unusually short great toes and abnormal thumbs. Females with the disorder have duplication of the genital tract. {ECO:0000269|PubMed:10839976, ECO:0000269|PubMed:12073020}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Guttmacher syndrome (GUTTS) [MIM:176305]: Dominantly inherited combination of distal limb and genital tract abnormalities. It has several features in common with hand-foot- genital syndrome, including hypoplastic first digits and hypospadias. Typical features not seen in hand-foot-genital syndrome include postaxial polydactyly of the hands and uniphalangeal second toes with absent nails. {ECO:0000269|PubMed:11968094}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.68929	.	.	.	122.9053	2.41409	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	chr7	27236537	chr7:27236537	C	T	.	PASS	AN=0;DP=87	GT	0/1
chr7	27236557	27236557	-	T	UTR3	HOXA13	NM_000522:c.*1259_*1260insA	.	.	.	.	.	DISEASE: Hand-foot-genital syndrome (HFG) [MIM:140000]: A disorder characterized by limb and genitourinary anomalies. Clinical features include small feet with unusually short great toes and abnormal thumbs. Females with the disorder have duplication of the genital tract. {ECO:0000269|PubMed:10839976, ECO:0000269|PubMed:12073020}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Guttmacher syndrome (GUTTS) [MIM:176305]: Dominantly inherited combination of distal limb and genital tract abnormalities. It has several features in common with hand-foot- genital syndrome, including hypoplastic first digits and hypospadias. Typical features not seen in hand-foot-genital syndrome include postaxial polydactyly of the hands and uniphalangeal second toes with absent nails. {ECO:0000269|PubMed:11968094}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.68929	.	.	.	122.9053	2.41409	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	64	chr7	27236557	chr7:27236557	G	GT	41	PASS	AN=2;DP=64	GT	0/1
chr7	44054022	44054022	A	G	ncRNA_intronic	POLR2J4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	161	chr7	44054022	chr7:44054022	A	G	.	PASS	AN=0;DP=161	GT	0/1
chr7	55242466	55242480	GAATTAAGAGAAGCA	-	exonic	EGFR	.	nonframeshift deletion	EGFR:NM_001346941:exon13:c.1435_1449del:p.E479_A483del,EGFR:NM_001346897:exon18:c.2101_2115del:p.E701_A705del,EGFR:NM_001346899:exon18:c.2101_2115del:p.E701_A705del,EGFR:NM_001346898:exon19:c.2236_2250del:p.E746_A750del,EGFR:NM_001346900:exon19:c.2077_2091del:p.E693_A697del,EGFR:NM_005228:exon19:c.2236_2250del:p.E746_A750del	0.99866453	0.00133547	2.97E-13	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. {ECO:0000269|PubMed:15118125, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:16672372}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Inflammatory skin and bowel disease, neonatal, 2 (NISBD2) [MIM:616069]: A disorder characterized by inflammatory features with neonatal onset, involving the skin, hair, and gut. The skin lesions involve perioral and perianal erythema, psoriasiform erythroderma, with flares of erythema, scaling, and widespread pustules. Gastrointestinal symptoms include malabsorptive diarrhea that is exacerbated by intercurrent gastrointestinal infections. The hair is short or broken, and the eyelashes and eyebrows are wiry and disorganized. {ECO:0000269|PubMed:24691054}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99968	0.98895	-2.160861741	1.439018636	119.9504	2.38669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	77	chr7	55242465	chr7:55242465	GGAATTAAGAGAAGCA	G	81	PASS	AN=2;DP=77	GT	0/1
chr7	64498715	64498715	-	GGAGGCGGAG	upstream	CCT6P3	dist=17	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	26	chr7	64498715	chr7:64498715	T	TGGAGGCGGAG	42	PASS	AN=2;DP=26	GT	0/1
chr7	66764425	66764426	AC	-	ncRNA_intronic	PMS2P4	.	.	.	.	.	.	.	0.0654	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	64	chr7	66764424	chr7:66764424	TAC	T	50	PASS	AN=2;DP=64	GT	0/1
chr7	87138689	87138689	T	A	exonic	ABCB1	.	nonsynonymous SNV	ABCB1:NM_001348946:exon26:c.A3391T:p.I1131F,ABCB1:NM_000927:exon27:c.A3391T:p.I1131F,ABCB1:NM_001348944:exon28:c.A3391T:p.I1131F,ABCB1:NM_001348945:exon30:c.A3601T:p.I1201F	0.734473812	0.265526186	1.52E-09	DISEASE: Inflammatory bowel disease 13 (IBD13) [MIM:612244]: A chronic, relapsing inflammation of the gastrointestinal tract with a complex etiology. It is subdivided into Crohn disease and ulcerative colitis phenotypes. Crohn disease may affect any part of the gastrointestinal tract from the mouth to the anus, but most frequently it involves the terminal ileum and colon. Bowel inflammation is transmural and discontinuous; it may contain granulomas or be associated with intestinal or perianal fistulas. In contrast, in ulcerative colitis, the inflammation is continuous and limited to rectal and colonic mucosal layers; fistulas and granulomas are not observed. Both diseases include extraintestinal inflammation of the skin, eyes, or joints. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.58236	0.67981	0.099178678	60.75725407	402.73587	4.20979	0.0	0.912	D	1.0	0.899	D	0.974	0.971	D	0.000	0.843	D	1	0.810	D	2.53	0.740	M	-3.17	0.931	D	-3.81	0.718	D	0.975	0.976	1.016	0.975	D	0.904	0.968	D	0.381	0.930	D	7.172	0.944	34	0.989	0.473	0.986	0.850	D	c	0.920	0.887	1.000	0.747	0.638	0.428	0	6.06	0.983	8.009	0.880	1.061	0.807	1.000	0.715	0.999	0.750	15.797	0.781	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	50	67	chr7	87138689	chr7:87138689	T	A	50	PASS	AN=2;DP=67	GT	0/1
chr7	87323210	87323210	T	-	intronic	ABCB1;RUNDC3B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	29	chr7	87323209	chr7:87323209	AT	A	50	PASS	AN=2;DP=29	GT	0/1
chr7	94027043	94027043	-	T	intronic	COL1A2	.	.	.	0.999754944	0.000245056	9.66E-16	DISEASE: Ehlers-Danlos syndrome 7B (EDS7B) [MIM:130060]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. Marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations. {ECO:0000269|PubMed:1577745, ECO:0000269|PubMed:2394758, ECO:0000269|PubMed:3680255}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 1 (OI1) [MIM:166200]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI1 is a non-deforming form with normal height or mild short stature, and no dentinogenesis imperfecta. {ECO:0000269|PubMed:16705691, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:1990009, ECO:0000269|PubMed:8456807, ECO:0000269|PubMed:8829649}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 2 (OI2) [MIM:166210]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI2 is characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency. {ECO:0000269|PubMed:10627137, ECO:0000269|PubMed:1284475, ECO:0000269|PubMed:1339453, ECO:0000269|PubMed:1385413, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1874719, ECO:0000269|PubMed:18996919, ECO:0000269|PubMed:2777764, ECO:0000269|PubMed:2914942, ECO:0000269|PubMed:7693712, ECO:0000269|PubMed:7891382, ECO:0000269|PubMed:7906591, ECO:0000269|PubMed:7959683, ECO:0000269|PubMed:8182080, ECO:0000269|Ref.33}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form (EDSCV) [MIM:225320]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. In addition to joint laxity, skin hyperextensibility and friability, and abnormal scar formation, patients have mitral valve prolapse and insufficiency, mitral regurgitation, and aortic insufficiency. {ECO:0000269|PubMed:16816023}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 3 (OI3) [MIM:259420]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI3 is characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:10408781, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1990009, ECO:0000269|PubMed:7520724, ECO:0000269|PubMed:7720740, ECO:0000269|PubMed:7749416, ECO:0000269|PubMed:7860070, ECO:0000269|PubMed:7881420, ECO:0000269|PubMed:8081394, ECO:0000269|PubMed:8444468, ECO:0000269|PubMed:8456807, ECO:0000269|PubMed:8723681, ECO:0000269|PubMed:8800927, ECO:0000269|PubMed:8829649}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 4 (OI4) [MIM:166220]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI4 is characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:1642148, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:2052622, ECO:0000269|PubMed:2064612, ECO:0000269|PubMed:2897363, ECO:0000269|PubMed:7693712, ECO:0000269|PubMed:8094076, ECO:0000269|PubMed:8401517, ECO:0000269|PubMed:8800927}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving COL1A2 may be a cause of lipoblastomas, which are benign tumors resulting from transformation of adipocytes, usually diagnosed in children. Translocation t(7;8)(p22;q13) with PLAG1.; 	0.99859	.	-1.144569759	6.363529134	161.91131	2.78024	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	53	chr7	94027043	chr7:94027043	C	CT	51	PASS	AN=2;DP=53	GT	0/1
chr7	98507900	98507900	G	A	exonic	TRRAP	.	synonymous SNV	TRRAP:NM_001244580:exon15:c.G1572A:p.V524V,TRRAP:NM_003496:exon15:c.G1572A:p.V524V	1	1.50E-21	1.65E-53	DISEASE: Note=TRRAP mutation Phe-722 has been frequently found in cutaneous malignant melanoma, suggesting that TRRAP may play a role in the pathogenesis of melanoma. {ECO:0000269|PubMed:21499247}.; 	0.90101	0.52705	-6.141724508	0.035385704	221.99559	3.22188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	chr7	98507900	chr7:98507900	G	A	.	PASS	AN=0;DP=25	GT	0/1
chr7	103202348	103202348	C	A	exonic	RELN	.	nonsynonymous SNV	RELN:NM_005045:exon35:c.G5263T:p.D1755Y,RELN:NM_173054:exon35:c.G5263T:p.D1755Y	1	2.44E-15	3.10E-43	DISEASE: Lissencephaly 2 (LIS2) [MIM:257320]: A classic type lissencephaly associated with ataxia, mental retardation, seizures and abnormalities of the cerebellum, hippocampus and brainstem. {ECO:0000269|PubMed:10973257}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epilepsy, familial temporal lobe, 7 (ETL7) [MIM:616436]: A focal form of epilepsy characterized by recurrent seizures that arise from foci within the temporal lobe. Seizures are usually accompanied by sensory symptoms, most often auditory in nature. {ECO:0000269|PubMed:26046367}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25073	.	-2.151227095	1.462609106	2605.03558	9.54865	0.006	0.632	D	0.997	0.899	D	0.956	0.850	D	0.000	0.843	D	1.000	0.588	D	2.125	0.592	M	1.59	0.288	T	-2.88	0.605	D	0.844	0.831	-0.849	0.521	T	0.186	0.537	T	0.039	0.587	D	5.137	0.693	25.4	0.995	0.650	0.976	0.754	D	c	0.662	0.639	1.000	0.747	0.624	0.395	0	5.78	0.914	5.628	0.672	0.935	0.490	1.000	0.715	0.500	0.271	20.012	0.974	Sialidases	.	.	0.5	.	59	chr7	103202348	chr7:103202348	C	A	.	PASS	AN=0;DP=59	GT	0/1
chr7	129690336	129690336	A	-	intronic	ZC3HC1	.	.	.	0.000510516	0.998179913	0.00130957	.	0.1856	.	0.242582624	69.45623968	3942.67551	12.41332	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	57	chr7	129690335	chr7:129690335	CA	C	57	PASS	AN=2;DP=57	GT	0/1
chr7	131113756	131113756	-	T	intronic	MKLN1	.	.	.	0.999577505	0.000422495	5.31E-11	.	0.35761	0.14611	-0.427900189	25.14744043	19.26303	0.66403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	49	chr7	131113756	chr7:131113756	C	CT	50	PASS	AN=2;DP=49	GT	0/1
chr7	151479545	151479545	C	T	intronic	PRKAG2	.	.	.	0.977557429	0.022442395	1.77E-07	DISEASE: Wolff-Parkinson-White syndrome (WPWS) [MIM:194200]: A supernormal conduction disorder characterized by the presence of one or several accessory atrioventricular connections, which can lead to episodes of sporadic tachycardia. {ECO:0000269|PubMed:11407343, ECO:0000269|PubMed:11748095}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 6 (CMH6) [MIM:600858]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. CMH6 patients present Wolff-Parkinson-White ventricular preexcitation, enlarged myocytes without myofiber disarray, and glycogen- containing cytosolic vacuoles within cardiomyocytes. {ECO:0000269|PubMed:11371514, ECO:0000269|PubMed:11827995}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glycogen storage disease of heart lethal congenital (GSDH) [MIM:261740]: Rare disease which leads to death within a few weeks to a few months after birth, through heart failure and respiratory compromise. {ECO:0000269|PubMed:15877279}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75824	0.19412	-0.867014353	10.72776598	322.64102	3.81555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	122	chr7	151479545	chr7:151479545	C	T	72	PASS	AN=2;DP=122	GT	0/1
chr8	22459801	22459801	C	T	exonic	C8orf58	.	synonymous SNV	C8orf58:NM_001013842:exon5:c.C855T:p.H285H,C8orf58:NM_001198827:exon5:c.C855T:p.H285H,C8orf58:NM_173686:exon5:c.C855T:p.H285H	7.26E-07	0.279282222	0.720717052	.	0.11805	.	0.775339069	87.13729653	146.34089	2.63608	0.0	0.912	D	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	-0.5	0.158	N	.	.	-0.984	0.341	T	0.106	0.388	T	.	.	.	-0.071	0.087	1.957	0.374	0.025	0.042	0.095	N	c	-0.485	-0.624	1.000	0.422	0.707	0.730	0	1.96	0.251	0.002	0.129	0.783	0.315	0.000	0.063	0.005	0.090	5.274	0.148	.	.	.	0.5	.	66	chr8	22459801	chr8:22459801	C	T	.	PASS	AN=0;DP=66	GT	0/1
chr8	53024435	53024435	A	-	UTR3	ST18	NM_014682:c.*1323delT	.	.	0.999009548	0.000990452	1.73E-11	.	0.47084	0.11285	-0.613589782	17.49823071	543.59199	4.74421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.89	48	chr8	53024434	chr8:53024434	TA	T	12.89	PASS	AN=0;DP=48	GT	0/1
chr8	102564947	102564947	C	T	exonic	GRHL2	.	nonsynonymous SNV	GRHL2:NM_001330593:exon3:c.C173T:p.P58L,GRHL2:NM_024915:exon3:c.C221T:p.P74L	0.999880613	0.000119387	1.21E-11	DISEASE: Deafness, autosomal dominant, 28 (DFNA28) [MIM:608641]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA28 is characterized by mild to moderate hearing loss across most frequencies that progresses to severe loss in the higher frequencies by the fifth decade. {ECO:0000269|PubMed:12393799}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ectodermal dysplasia/short stature syndrome (ECTDS) [MIM:616029]: An autosomal recessive ectodermal dysplasia syndrome characterized by nail dystrophy and/or loss, oral mucosa and/or tongue pigmentation, abnormal dentition, keratoderma affecting the margins of the palms and soles, focal hyperkeratosis of the dorsal aspects of the hands and feet, and short stature. {ECO:0000269|PubMed:25152456}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.94042	0.15234	-0.402212257	26.7338995	378.61795	4.10168	0.0	0.912	D	1.0	0.899	D	0.997	0.916	D	0.000	0.843	D	1	0.810	D	2.88	0.837	M	-0.03	0.631	T	-7.49	0.950	D	0.783	0.774	0.045	0.832	D	0.489	0.806	T	0.177	0.853	D	7.208	0.945	34	0.999	0.945	0.983	0.808	D	c	0.853	0.814	1.000	0.747	0.732	0.924	0	5.47	0.803	6.626	0.739	0.935	0.490	1.000	0.715	1.000	0.888	18.918	0.925	.	.	.	0.5	41	43	chr8	102564947	chr8:102564947	C	T	41	PASS	AN=2;DP=43	GT	0/1
chr8	104439486	104439486	-	T	intronic	DCAF13	.	.	.	6.93E-05	0.998985212	0.000945515	.	0.87388	0.08975	0.846940207	88.47605567	3332.2896	11.04368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	7	chr8	104439486	chr8:104439486	G	GT	40	PASS	AN=2;DP=7	GT	0/1
chr8	124822507	124822507	-	T	intronic	FAM91A1	.	.	.	0.515693527	0.484306207	2.67E-07	.	0.30469	.	-0.622676946	17.30950696	54.36063	1.47405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	55	chr8	124822507	chr8:124822507	C	CT	65	PASS	AN=2;DP=55	GT	0/1
chr9	79634988	79634988	C	T	exonic	FOXB2	.	nonsynonymous SNV	FOXB2:NM_001013735:exon1:c.C418T:p.H140Y	2.39E-06	0.086886107	0.913111501	.	0.57849	0.10915	.	.	70.49669	1.74683	0.348	0.124	T	0.678	0.394	P	0.157	0.329	B	.	.	.	0.894	0.278	N	0.695	0.181	N	0.82	0.481	T	-0.15	0.093	N	0.282	0.341	-1.063	0.111	T	0.079	0.314	T	0.265	0.897	D	-0.920	0.035	0.023	0.603	0.063	0.626	0.316	D	c	-0.437	-0.470	1.000	0.500	0.598	0.340	0	3.69	0.413	2.506	0.448	0.752	0.309	0.624	0.277	0.250	0.228	12.329	0.542	.	.	.	0.5	.	21	chr9	79634988	chr9:79634988	C	T	.	PASS	AN=0;DP=21	GT	0/1
chr9	131457105	131457106	GG	-	UTR3	SET	NM_001122821:c.*162_*163delGG;NM_001248000:c.*162_*163delGG;NM_003011:c.*162_*163delGG;NM_001248001:c.*162_*163delGG	.	.	0.96336428	0.036564183	7.15E-05	DISEASE: Note=A chromosomal aberration involving SET is found in some cases of acute undifferentiated leukemia (AUL). Translocation t(6;9)(q21;q34.1) with NUP214/CAN.; 	0.60962	0.29577	0.3032669	72.009908	21.10998	0.71452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	214	chr9	131457104	chr9:131457104	TGG	T	78	PASS	AN=2;DP=214	GT	0/1
chr10	12871236	12871236	A	-	UTR3	CAMK1D	NM_153498:c.*350delA	.	.	0.993807052	0.006192043	9.05E-07	.	0.18445	0.13388	-0.271755481	34.31823543	16.76649	0.58938	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	12	chr10	12871235	chr10:12871235	CA	C	43	PASS	AN=2;DP=12	GT	0/1
chr10	28908452	28908452	-	T	intronic	WAC	.	.	.	0.999891943	0.000108057	4.68E-11	.	0.23812	0.12474	-0.867014353	10.72776598	545.45625	4.75017	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	68	chr10	28908452	chr10:28908452	C	CT	51	PASS	AN=2;DP=68	GT	0/1
chr10	46968680	46968680	G	A	exonic	SYT15	.	stopgain	SYT15:NM_031912:exon3:c.C256T:p.R86X,SYT15:NM_181519:exon3:c.C256T:p.R86X	3.40E-18	0.000175723	0.999824277	.	0.03366	0.12113	0.780798785	87.24345364	417.36536	4.27585	.	.	.	.	.	.	.	.	.	0.565	0.113	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.567	0.963	35	0.998	0.901	0.625	0.315	D	c	0.334	0.083	1.000	0.747	0.765	0.991	0	1.43	0.215	1.336	0.332	0.722	0.304	0.918	0.317	0.459	0.264	8.235	0.306	.	.	.	0.5	.	98	chr10	46968680	chr10:46968680	G	A	.	PASS	AN=0;DP=98	GT	0/1
chr10	63423610	63423610	C	T	intronic	C10orf107	.	.	.	0.00079093	0.774574838	0.224634231	.	0.07541	.	-0.404032746	26.53338051	18.06284	0.63027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	32	chr10	63423610	chr10:63423610	C	T	50	PASS	AN=2;DP=32	GT	0/1
chr10	63853315	63853315	G	T	UTR3	ARID5B	NM_032199:c.*526G>T;NM_001244638:c.*526G>T	.	.	0.999889943	0.000110057	4.89E-11	DISEASE: Note=Defects in ARID5B may be a cause of susceptibility to coronary atherosclerosis in the Japanese population.; DISEASE: Leukemia, acute lymphoblastic (ALL) [MIM:613065]: A subtype of acute leukemia, a cancer of the white blood cells. ALL is a malignant disease of bone marrow and the most common malignancy diagnosed in children. The malignant cells are lymphoid precursor cells (lymphoblasts) that are arrested in an early stage of development. The lymphoblasts replace the normal marrow elements, resulting in a marked decrease in the production of normal blood cells. Consequently, anemia, thrombocytopenia, and neutropenia occur to varying degrees. The lymphoblasts also proliferate in organs other than the marrow, particularly the liver, spleen, and lymphonodes. {ECO:0000269|PubMed:19684603, ECO:0000269|PubMed:19684604, ECO:0000269|PubMed:20042726, ECO:0000269|PubMed:20054350, ECO:0000269|PubMed:20189245, ECO:0000269|PubMed:20460642, ECO:0000269|PubMed:21098271}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.79023	0.1136	-1.03794674	7.832035858	133.85694	2.51593	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	54	chr10	63853315	chr10:63853315	G	T	.	PASS	AN=0;DP=54	GT	0/1
chr10	96448040	96448040	-	T	intronic	CYP2C18	.	.	.	5.27E-08	0.227331799	0.772668149	.	0.03976	0.24838	1.177658736	92.77541873	2268.87678	8.81391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	44	chr10	96448040	chr10:96448040	C	CT	40	PASS	AN=2;DP=44	GT	0/1
chr10	120923662	120923662	G	A	exonic	SFXN4	.	nonsynonymous SNV	SFXN4:NM_213649:exon2:c.C158T:p.T53I	0.00014832	0.992238286	0.007613393	DISEASE: Combined oxidative phosphorylation deficiency 18 (COXPD18) [MIM:615578]: An autosomal recessive disorder of mitochondrial dysfunction characterized by intrauterine growth retardation, hypotonia, visual impairment, speech delay, and lactic acidosis associated with decreased mitochondrial respiratory chain activity. Affected patients may also show hematologic abnormalities, mainly macrocytic anemia. {ECO:0000269|PubMed:24119684}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.04555	0.06327	-0.714505427	14.4019816	9.01689	0.33046	0.083	0.330	T	0.953	0.523	P	0.444	0.441	B	0.627	0.107	N	0.991	0.241	N	2.32	0.666	M	1.57	0.293	T	-2.25	0.503	N	0.141	0.166	-1.044	0.161	T	0.070	0.285	T	0.026	0.492	D	1.767	0.273	14.80	0.990	0.508	0.347	0.249	N	c	-0.443	-0.563	1.000	0.415	0.706	0.609	0	1.34	0.209	1.096	0.304	-0.314	0.078	0.861	0.304	0.063	0.172	6.114	0.192	.	.	.	0.5	.	53	chr10	120923662	chr10:120923662	G	A	.	PASS	AN=0;DP=53	GT	0/1
chr10	128780161	128780161	-	T	intronic	DOCK1	.	.	.	0.36842317	0.63157683	9.50E-14	.	0.11584	0.19704	.	.	350.01956	3.96565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	24	chr10	128780161	chr10:128780161	G	GT	58	PASS	AN=2;DP=24	GT	0/1
chr11	403122	403122	G	A	exonic	PKP3	.	synonymous SNV	PKP3:NM_007183:exon9:c.G1782A:p.K594K,PKP3:NM_001303029:exon10:c.G1827A:p.K609K	0.194350415	0.805198634	0.000450952	.	0.50658	0.11351	.	.	238.13226	3.33382	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	68	chr11	403122	chr11:403122	G	A	72	PASS	AN=2;DP=68	GT	0/1
chr11	1576396	1576396	G	A	UTR3	DUSP8	NM_004420:c.*1352C>T	.	.	0.684472965	0.311172545	0.00435449	.	0.12453	0.12894	.	.	35.08836	1.06434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	38	chr11	1576396	chr11:1576396	G	A	51	PASS	AN=2;DP=38	GT	0/1
chr11	2336456	2336456	A	G	intronic	TSPAN32	.	.	.	0.000537261	0.88875402	0.110708719	.	0.07365	.	0.376678994	75.50719509	156.95947	2.73665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	382	chr11	2336456	chr11:2336456	A	G	76	PASS	AN=2;DP=382	GT	0/1
chr11	5443988	5444063	GATCCGCCTGGTCTGTGCTGACATCAGGCTCAACAGCTGGTATGGATTTGCTCTTGCCTTGCTCATTATTATCGTG	-	exonic	OR51Q1	.	frameshift deletion	OR51Q1:NM_001004757:exon1:c.558_633del:p.R188Lfs*4	0.003685054	0.630936593	0.365378353	.	0.12799	.	2.754408354	98.99150743	12173.23218	23.67045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	42	chr11	5443987	chr11:5443987	TGATCCGCCTGGTCTGTGCTGACATCAGGCTCAACAGCTGGTATGGATTTGCTCTTGCCTTGCTCATTATTATCGTG	T	40	PASS	AN=2;DP=42	GT	0/1
chr11	21305564	21305564	G	C	intronic	NELL1	.	.	.	2.17E-09	0.99233506	0.007664938	.	0.16311	0.14813	0.207589927	67.52182118	890.70295	5.81461	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	13	chr11	21305564	chr11:21305564	G	C	56	PASS	AN=2;DP=13	GT	0/1
chr11	64367140	64367140	T	C	intronic	SLC22A12	.	.	.	4.90E-06	0.856135783	0.143859316	.	0.126	0.14076	-1.153638777	6.233781552	97.64363	2.13702	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	chr11	64367140	chr11:64367140	T	C	.	PASS	AN=0;DP=45	GT	0/1
chr11	65266480	65266480	T	C	ncRNA_exonic	MALAT1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	200	chr11	65266480	chr11:65266480	T	C	111	PASS	AN=2;DP=200	GT	0/1
chr11	70348840	70348840	-	C	intronic	SHANK2	.	.	.	0.99992017	7.98E-05	2.24E-11	DISEASE: Autism 17 (AUTS17) [MIM:613436]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:20473310}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.35021	.	.	.	1233.68596	6.63651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	44	chr11	70348840	chr11:70348840	G	GC	78	PASS	AN=2;DP=44	GT	0/1
chr11	73765608	73765608	T	-	intronic	C2CD3	.	.	.	8.08E-10	0.999999551	4.48E-07	DISEASE: Orofaciodigital syndrome 14 (OFD14) [MIM:615948]: A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by malformations of the oral cavity, face and digits, and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD14 patients show severe microcephaly, cerebral malformations the molar tooth sign, and intellectual disability in addition to canonical OFDS features. {ECO:0000269|PubMed:24997988}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.37109	.	2.177297739	98.07737674	7679.56022	18.83084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	17.42	17	chr11	73765607	chr11:73765607	CT	C	17.42	PASS	AN=0;DP=17	GT	0/1
chr11	78614515	78614517	GCG	-	exonic	TENM4	.	nonframeshift deletion	TENM4:NM_001098816:exon7:c.545_547del:p.P182del	0.999718776	0.000281224	3.30E-14	.	0.59536	.	-1.696530647	2.589054022	1180.19147	6.52237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	37	chr11	78614514	chr11:78614514	AGCG	A	55	PASS	AN=2;DP=37	GT	0/1
chr11	85692737	85692737	G	-	intronic	PICALM	.	.	.	0.97208309	0.027916606	3.03E-07	.	0.97843	0.13037	-0.490397599	22.50530786	39.60281	1.16712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.62	38	chr11	85692736	chr11:85692736	AG	A	13.62	PASS	AN=0;DP=38	GT	0/1
chr11	86198530	86198530	T	-	intronic	ME3	.	.	.	1.14E-05	0.98774607	0.012242511	.	0.21938	0.18427	-0.821100135	11.88369899	2619.18186	9.5929	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	52	chr11	86198529	chr11:86198529	GT	G	51	PASS	AN=2;DP=52	GT	0/1
chr11	118443064	118443064	C	-	upstream	ARCN1	dist=38	.	.	0.999850871	0.000149129	1.03E-10	.	0.31441	0.17611	-0.626318434	17.03231894	55.4936	1.49655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	33	chr11	118443063	chr11:118443063	GC	G	79	PASS	AN=2;DP=33	GT	0/1
chr12	29648275	29648275	G	A	exonic	OVCH1	.	nonsynonymous SNV	OVCH1:NM_183378:exon4:c.C397T:p.R133C	1.53E-28	1.88E-05	0.999981223	.	0.058	.	.	.	4524.95189	13.51306	0.052	0.390	T	0.855	0.451	P	0.285	0.388	B	.	.	.	1	0.090	P	1.665	0.427	L	-2.49	0.892	D	-2.21	0.496	N	0.148	0.175	-0.972	0.368	T	0.000	0.000	T	.	.	.	1.303	0.221	12.28	0.865	0.161	0.010	0.039	N	c	-0.770	-0.946	0.003	0.097	0.554	0.246	0	0.63	0.168	-0.542	0.061	-1.030	0.021	0.000	0.063	0.002	0.062	5.503	0.160	Peptidase S1, PA clan|Serine proteases, trypsin domain	.	.	0.5	64	19	chr12	29648275	chr12:29648275	G	A	64	PASS	AN=2;DP=19	GT	0/1
chr12	48501161	48501161	A	T	exonic	PFKM	.	nonsynonymous SNV	PFKM:NM_001166686:exon2:c.A5T:p.H2L	6.03E-07	0.999707802	0.000291594	DISEASE: Glycogen storage disease 7 (GSD7) [MIM:232800]: A metabolic disorder characterized by exercise intolerance with associated nausea and vomiting, muscle cramping, exertional myopathy and compensated hemolysis. Short bursts of intense activity are particularly difficult. Severe muscle cramps and myoglobinuria develop after vigorous exercise. {ECO:0000269|PubMed:22133655, ECO:0000269|PubMed:24427140, ECO:0000269|PubMed:7513946, ECO:0000269|PubMed:7825568, ECO:0000269|PubMed:8889589}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25899	0.78377	-0.464712395	23.5727766	3843.53437	12.20917	0.056	0.381	T	.	.	.	.	.	.	0.209	0.164	N	0.996	0.231	P	.	.	.	-1.33	0.872	T	-0.17	0.129	N	0.049	0.150	-0.924	0.450	T	0.000	0.000	T	.	.	.	2.873	0.406	21.7	0.850	0.151	0.097	0.152	N	c	-0.630	-0.693	1.000	0.747	0.421	0.056	0	-2.34	0.063	-1.241	0.030	-0.506	0.051	0.233	0.245	0.790	0.333	8.661	0.331	.	ENSG00000152556.11|ENSG00000240399.1|ENSG00000152556.11|ENSG00000139219.13|ENSG00000167528.8	Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Testis|Whole_Blood	0.5	72	11	chr12	48501161	chr12:48501161	A	T	72	PASS	AN=2;DP=11	GT	1/0
chr12	55159834	55159834	T	-	intergenic	DCD;MUCL1	dist=117557;dist=88465	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	69	chr12	55159833	chr12:55159833	AT	A	51	PASS	AN=2;DP=69	GT	0/1
chr12	75720278	75720278	T	C	exonic	CAPS2	.	nonsynonymous SNV	CAPS2:NM_001286547:exon2:c.A22G:p.M8V,CAPS2:NM_032606:exon2:c.A58G:p.M20V	2.65E-09	0.272459498	0.727540499	.	0.079	0.09221	0.198490371	67.30360934	2043.71225	8.33443	0.0	0.912	D	0.993	0.637	D	0.956	0.680	D	0.233	0.159	N	0.897	0.810	D	1.87	0.498	L	1.51	0.309	T	-0.7	0.247	N	0.603	0.628	-0.974	0.363	T	0.100	0.371	T	0.006	0.146	T	3.724	0.505	23.3	0.973	0.326	0.881	0.476	D	c	0.272	0.256	0.104	0.165	0.554	0.246	0	4.41	0.524	4.606	0.606	1.061	0.807	1.000	0.715	0.707	0.311	13.046	0.582	.	.	.	0.5	70	32	chr12	75720278	chr12:75720278	T	C	70	PASS	AN=2;DP=32	GT	0/1
chr12	88512304	88512304	-	T	exonic	CEP290	.	frameshift insertion	CEP290:NM_025114:exon17:c.1666dupA:p.I556Nfs*19	1.04E-34	0.00416173	0.99583827	DISEASE: Joubert syndrome 5 (JBTS5) [MIM:610188]: A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. Joubert syndrome type 5 shares the neurologic and neuroradiologic features of Joubert syndrome together with severe retinal dystrophy and/or progressive renal failure characterized by nephronophthisis. {ECO:0000269|PubMed:16682970, ECO:0000269|PubMed:16682973, ECO:0000269|PubMed:22425360}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Senior-Loken syndrome 6 (SLSN6) [MIM:610189]: A renal- retinal disorder characterized by progressive wasting of the filtering unit of the kidney (nephronophthisis), with or without medullary cystic renal disease, and progressive eye disease. Typically this disorder becomes apparent during the first year of life. {ECO:0000269|PubMed:20683928}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leber congenital amaurosis 10 (LCA10) [MIM:611755]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:16909394}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Meckel syndrome 4 (MKS4) [MIM:611134]: A disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly. {ECO:0000269|PubMed:17564974}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Antibodies against CEP290 are present in sera from patients with cutaneous T-cell lymphomas, but not in the healthy control population. {ECO:0000269|PubMed:11149944}.; DISEASE: Bardet-Biedl syndrome 14 (BBS14) [MIM:615991]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:18327255}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.48442	0.31068	0.374677996	75.3066761	2616.79176	9.5828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	18	chr12	88512304	chr12:88512304	A	AT	41	PASS	AN=2;DP=18	GT	0/1
chr12	95479478	95479478	G	C	intronic	FGD6	.	.	.	0.995227689	0.004772311	3.29E-11	.	0.18424	0.0913	-1.076610636	7.324840764	1000.15705	6.09179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	10	chr12	95479478	chr12:95479478	G	C	43	PASS	AN=2;DP=10	GT	0/1
chr12	111180637	111180637	C	-	UTR5	PPP1CC	NM_002710:c.-125delG;NM_001244974:c.-125delG	.	.	0.944905081	0.055054589	4.03E-05	.	0.99939	0.29199	-0.031067188	51.03798066	4.80302	0.1749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	51	chr12	111180636	chr12:111180636	TC	T	55	PASS	AN=2;DP=51	GT	0/1
chr12	133398711	133398711	C	A	exonic	GOLGA3	.	nonsynonymous SNV	GOLGA3:NM_001172557:exon2:c.G4T:p.D2Y,GOLGA3:NM_005895:exon2:c.G4T:p.D2Y	0.991564256	0.008435744	5.42E-12	.	0.42503	0.13258	-0.571624906	18.96673744	4390.25176	13.22841	0.003	0.721	D	0.997	0.764	D	0.912	0.657	D	0.010	0.303	N	0.959	0.810	D	2.14	0.601	M	1.53	0.394	T	-2.43	0.532	N	0.517	0.582	-0.745	0.583	T	0.213	0.574	T	0.047	0.629	D	5.305	0.718	25.8	0.991	0.531	0.985	0.837	D	c	0.523	0.484	1.000	0.489	0.707	0.730	0	5.6	0.849	4.449	0.595	0.852	0.362	1.000	0.715	0.521	0.274	16.776	0.853	.	.	.	0.5	.	69	chr12	133398711	chr12:133398711	C	A	.	PASS	AN=0;DP=69	GT	0/1
chr13	50570574	50570574	T	-	ncRNA_exonic	MIR3613	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	38	chr13	50570573	chr13:50570573	CT	C	62	PASS	AN=2;DP=38	GT	0/1
chr14	39788502	39788502	T	-	intronic	MIA2	.	.	.	0.00020882	0.908098694	0.091692485	.	0.18559	0.10293	1.133561642	92.28591649	1216.13549	6.59678	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	45	chr14	39788501	chr14:39788501	CT	C	57	PASS	AN=2;DP=45	GT	0/1
chr14	63848889	63848889	A	-	intronic	PPP2R5E	.	.	.	0.999433464	0.000566533	2.65E-09	.	0.55655	0.14896	-0.405853867	26.23260203	8.32866	0.3049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	41	chr14	63848888	chr14:63848888	GA	G	41	PASS	AN=2;DP=41	GT	0/1
chr14	74970076	74970076	G	A	exonic	LTBP2	.	synonymous SNV	LTBP2:NM_000428:exon33:c.C4734T:p.D1578D	0.018734688	0.981265309	2.42E-09	DISEASE: Glaucoma 3, primary congenital, D (GLC3D) [MIM:613086]: An autosomal recessive form of primary congenital glaucoma (PCG). PCG is characterized by marked increase of intraocular pressure at birth or early childhood, large ocular globes (buphthalmos) and corneal edema. It results from developmental defects of the trabecular meshwork and anterior chamber angle of the eye that prevent adequate drainage of aqueous humor. {ECO:0000269|PubMed:19361779}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma (MSPKA) [MIM:251750]: A rare disease characterized by smaller and more spherical lenses than normal bilaterally, an increased anteroposterior thickness of the lens, and highly myopic eyes. Lens dislocation or subluxation may occur, leading to defective accommodation. {ECO:0000269|PubMed:20617341}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Weill-Marchesani syndrome 3 (WMS3) [MIM:614819]: A rare connective tissue disorder characterized by short stature, brachydactyly, joint stiffness, and eye abnormalities including microspherophakia, ectopia lentis, severe myopia and glaucoma. {ECO:0000269|PubMed:22539340}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.34261	0.09147	-1.545648077	3.290870488	1221.56268	6.60795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	83	chr14	74970076	chr14:74970076	G	A	.	PASS	AN=0;DP=83	GT	0/1
chr14	94703987	94703987	G	-	exonic	PPP4R4	.	frameshift deletion	PPP4R4:NM_001348142:exon8:c.574delG:p.E192Kfs*20,PPP4R4:NM_058237:exon8:c.817delG:p.E273Kfs*20,PPP4R4:NM_001348144:exon9:c.496delG:p.E166Kfs*20,PPP4R4:NM_001348143:exon10:c.496delG:p.E166Kfs*20	0.005674255	0.994325407	3.39E-07	.	0.10634	0.08878	-1.085675268	7.147912243	115.24346	2.33468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	32	chr14	94703986	chr14:94703986	TG	T	51	PASS	AN=2;DP=32	GT	0/1
chr14	100594948	100594948	C	T	exonic	EVL	.	nonsynonymous SNV	EVL:NM_001330221:exon6:c.C574T:p.P192S,EVL:NM_016337:exon6:c.C580T:p.P194S	0.99261527	0.007384449	2.82E-07	.	0.74284	0.16663	-0.359940251	28.93371078	237.51255	3.32761	0.376	0.912	T	0.78	0.423	P	0.265	0.383	B	0.000	0.481	D	1.000	0.488	D	2.74	0.803	M	-0.78	0.736	T	-4.61	0.795	D	0.28	0.489	-0.396	0.722	T	0.353	0.717	T	0.220	0.878	D	4.071	0.547	23.7	0.997	0.828	0.990	0.895	D	c	0.264	0.301	1.000	0.747	0.672	0.522	0	3.87	0.437	7.005	0.759	0.781	0.315	1.000	0.715	0.994	0.587	14.989	0.709	.	.	.	0.5	65	188	chr14	100594948	chr14:100594948	C	T	65	PASS	AN=2;DP=188	GT	0/1
chr15	23690415	23690415	-	TGTGC	intronic	GOLGA6L2	.	.	.	8.97E-06	0.322765802	0.677225227	.	.	.	.	.	13588.28081	25.3545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	33	chr15	23690415	chr15:23690415	T	TTGTGC	59	PASS	AN=2;DP=33	GT	0/1
chr15	35273705	35273705	T	C	exonic	ZNF770	.	nonsynonymous SNV	ZNF770:NM_014106:exon3:c.A1931G:p.Y644C	0.827513247	0.1723277	0.000159054	.	0.37639	0.0946	-0.442665927	24.53408823	53.00521	1.44576	0.037	0.430	D	1.0	0.899	D	0.979	0.728	D	0.000	0.481	D	0.891	0.279	N	1.005	0.253	L	2.26	0.176	T	-2.57	0.555	D	0.813	0.801	-1.077	0.078	T	0.076	0.306	T	0.011	0.278	T	4.350	0.582	24.1	0.997	0.820	0.957	0.654	D	c	0.578	0.600	1.000	0.747	0.672	0.522	0	5.27	0.737	3.059	0.494	1.061	0.807	1.000	0.715	1.000	0.888	15.350	0.740	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	64	60	chr15	35273705	chr15:35273705	T	C	64	PASS	AN=2;DP=60	GT	0/1
chr15	66629410	66629411	AC	-	exonic	TIPIN	.	stopgain	TIPIN:NM_001289986:exon7:c.488_489del:p.C163fs*0,TIPIN:NM_017858:exon8:c.791_792del:p.C264fs*0	0.009832085	0.942185447	0.047982468	.	0.80134	0.08685	0.72761005	86.08162302	1665.32698	7.53505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.27	22	chr15	66629409	chr15:66629409	TAC	T	12.27	PASS	AN=0;DP=22	GT	0/1
chr16	29922505	29922505	G	-	intronic	KCTD13	.	.	.	0.791960934	0.206734677	0.00130439	.	0.38266	0.08839	-0.339715008	30.06605331	12.10685	0.43891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	69	chr16	29922504	chr16:29922504	AG	A	41	PASS	AN=2;DP=69	GT	0/1
chr16	57101244	57101244	A	G	intronic	NLRC5	.	.	.	6.72E-05	0.999932818	2.78E-09	.	0.07927	0.08967	0.514279338	80.30195801	898.09245	5.83754	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	57	chr16	57101244	chr16:57101244	A	G	70	PASS	AN=2;DP=57	GT	0/1
chr16	58021306	58021306	C	G	exonic	TEPP	.	synonymous SNV	TEPP:NM_199046:exon8:c.C873G:p.V291V,TEPP:NM_199456:exon8:c.C792G:p.V264V	6.80E-05	0.729947501	0.269984542	.	.	.	-0.069700724	48.54328851	39.64027	1.16858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	91	chr16	58021306	chr16:58021306	C	G	85	PASS	AN=2;DP=91	GT	0/1
chr16	67660381	67660381	C	T	intronic	CTCF	.	.	.	0.997924958	0.002075029	1.27E-08	DISEASE: Mental retardation, autosomal dominant 21 (MRD21) [MIM:615502]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Additional MRD21 features include short stature, microcephaly, and developmental delay. {ECO:0000269|PubMed:23746550}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.78428	0.25142	-0.293801652	32.93819297	9.66001	0.35497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	90	chr16	67660381	chr16:67660381	C	T	.	PASS	AN=0;DP=90	GT	0/1
chr16	74372596	74372596	-	A	ncRNA_intronic	LOC283922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.95	37	chr16	74372596	chr16:74372596	C	CA	13.95	PASS	AN=0;DP=37	GT	0/1
chr16	75269958	75269958	-	CA	intronic	BCAR1	.	.	.	0.992956578	0.007043171	2.51E-07	.	0.47335	.	1.53037684	95.51191319	778.41129	5.52069	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	19	chr16	75269958	chr16:75269958	C	CCA	60	PASS	AN=2;DP=19	GT	0/1
chr17	16344524	16344524	A	-	ncRNA_exonic	LRRC75A-AS1	.	.	.	.	.	.	.	0.01204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	20	chr17	16344523	chr17:16344523	CA	C	57	PASS	AN=2;DP=20	GT	0/1
chr17	29482988	29482988	-	T	intronic	NF1	.	.	.	0.999999846	1.54E-07	1.06E-27	DISEASE: Neurofibromatosis 1 (NF1) [MIM:162200]: A disease characterized by patches of skin pigmentation (cafe-au-lait spots), Lisch nodules of the iris, tumors in the peripheral nervous system and fibromatous skin tumors. Individuals with the disorder have increased susceptibility to the development of benign and malignant tumors. {ECO:0000269|PubMed:10220149, ECO:0000269|PubMed:10336779, ECO:0000269|PubMed:10607834, ECO:0000269|PubMed:10712197, ECO:0000269|PubMed:10980545, ECO:0000269|PubMed:11258625, ECO:0000269|PubMed:11735023, ECO:0000269|PubMed:11857752, ECO:0000269|PubMed:12522551, ECO:0000269|PubMed:12552569, ECO:0000269|PubMed:12746402, ECO:0000269|PubMed:1302608, ECO:0000269|PubMed:15060124, ECO:0000269|PubMed:15146469, ECO:0000269|PubMed:15520408, ECO:0000269|PubMed:15523642, ECO:0000269|PubMed:15948193, ECO:0000269|PubMed:17160901, ECO:0000269|PubMed:2114220, ECO:0000269|PubMed:21838856, ECO:0000269|PubMed:23758643, ECO:0000269|PubMed:24413922, ECO:0000269|PubMed:7981679, ECO:0000269|PubMed:8081387, ECO:0000269|PubMed:8544190, ECO:0000269|PubMed:8807336, ECO:0000269|PubMed:8834249, ECO:0000269|PubMed:9003501, ECO:0000269|PubMed:9101300, ECO:0000269|PubMed:9150739, ECO:0000269|PubMed:9298829, ECO:0000269|PubMed:9668168}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Watson syndrome (WTSN) [MIM:193520]: A syndrome characterized by the presence of pulmonary stenosis, cafe-au-lait spots, and mental retardation. It is considered as an atypical form of neurofibromatosis. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Familial spinal neurofibromatosis (FSNF) [MIM:162210]: Considered to be an alternative form of neurofibromatosis, showing multiple spinal tumors. {ECO:0000269|PubMed:11704931}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321]: Characterized by manifestations of both NF1 and Noonan syndrome (NS). NS is a disorder characterized by dysmorphic facial features, short stature, hypertelorism, cardiac anomalies, deafness, motor delay, and a bleeding diathesis. {ECO:0000269|PubMed:12707950, ECO:0000269|PubMed:16380919, ECO:0000269|PubMed:19845691}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.6001	0.90845	-3.091147521	0.471809389	198.4465	3.04463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	31	chr17	29482988	chr17:29482988	C	CT	40	PASS	AN=2;DP=31	GT	0/1
chr17	36883483	36883483	-	T	UTR3	MLLT6	NM_005937:c.*1632_*1633insT	.	.	0.998762157	0.001237842	7.29E-10	DISEASE: Note=A chromosomal aberration involving MLLT6 is associated with acute leukemias. Translocation t(11;17)(q23;q21) with KMT2A/MLL1. The result is a rogue activator protein.; 	0.50287	0.15426	-0.020150552	52.25288983	264.58482	3.48969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	44	chr17	36883483	chr17:36883483	G	GT	51	PASS	AN=2;DP=44	GT	0/1
chr17	38349645	38349645	C	T	exonic	RAPGEFL1	.	nonsynonymous SNV	RAPGEFL1:NM_001303533:exon14:c.C1387T:p.R463C,RAPGEFL1:NM_001303534:exon14:c.C1369T:p.R457C	0.874145904	0.125840265	1.38E-05	.	0.42544	.	-0.758599262	13.32861524	28.15111	0.90201	0.0	0.912	D	1.0	0.899	D	0.973	0.749	D	0.000	0.497	D	1	0.810	D	2.675	0.786	M	1.45	0.325	T	-7.14	0.941	D	0.952	0.949	-0.693	0.608	T	0.201	0.558	T	0.061	0.685	D	7.745	0.955	35	0.999	0.993	0.936	0.583	D	c	0.669	0.624	0.998	0.358	0.696	0.567	0	4.63	0.570	0.506	0.222	0.852	0.362	0.998	0.411	1.000	0.888	13.063	0.583	Ras guanine nucleotide exchange factor domain|Ras guanine-nucleotide exchange factors catalytic domain;Ras guanine nucleotide exchange factor domain|Ubiquitin-related domain	.	.	0.5	39	69	chr17	38349645	chr17:38349645	C	T	39	PASS	AN=2;DP=69	GT	0/1
chr17	39033672	39033672	-	T	intronic	KRT20	.	.	.	5.58E-06	0.672378198	0.327616222	.	0.33628	0.25521	0.176444282	66.07100731	89.49778	2.03437	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	20	chr17	39033672	chr17:39033672	G	GT	59	PASS	AN=2;DP=20	GT	0/1
chr17	40461067	40461067	A	G	exonic	STAT5A	.	nonsynonymous SNV	STAT5A:NM_001288719:exon16:c.A1975G:p.K659E,STAT5A:NM_001288720:exon16:c.A1972G:p.K658E,STAT5A:NM_001288718:exon17:c.A2065G:p.K689E,STAT5A:NM_003152:exon18:c.A2065G:p.K689E	0.999866029	0.000133971	1.60E-11	.	0.68233	0.58998	-0.644723694	16.52512385	205.21053	3.09506	0.291	0.215	T	0.063	0.219	B	0.023	0.262	B	0.587	0.111	N	1.000	0.588	D	2.645	0.776	M	-3.96	0.962	D	-1.24	0.314	N	0.668	0.678	0.455	0.899	D	0.831	0.944	D	0.084	0.744	D	1.099	0.200	11.21	0.949	0.252	0.991	0.912	D	c	-0.155	-0.073	1.000	0.747	0.672	0.522	0	4.91	0.638	9.161	0.938	1.140	0.893	1.000	0.715	0.212	0.220	14.570	0.677	SH2 domain	.	.	0.5	98	69	chr17	40461067	chr17:40461067	A	G	98	PASS	AN=2;DP=69	GT	0/1
chr17	40819937	40819937	G	A	UTR3	PLEKHH3	NM_024927:c.*208C>T	.	.	0.003760662	0.994437387	0.001801951	.	0.57588	0.09682	-0.955204708	9.170794999	149.26629	2.66346	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	85	chr17	40819937	chr17:40819937	G	A	.	PASS	AN=0;DP=85	GT	0/1
chr17	45623336	45623336	C	T	exonic	NPEPPS	.	nonsynonymous SNV	NPEPPS:NM_006310:exon2:c.C317T:p.S106L,NPEPPS:NM_001330257:exon3:c.C305T:p.S102L	0.99990592	9.41E-05	6.76E-12	.	0.2064	0.20026	0.042348793	57.31304553	51.85467	1.42259	0.103	0.405	T	0.367	0.323	B	0.166	0.398	B	0.000	0.843	D	1	0.810	D	1.53	0.389	L	4.2	0.027	T	-2.01	0.463	N	0.565	0.607	-0.941	0.425	T	0.019	0.080	T	0.018	0.405	T	3.588	0.489	23.2	0.999	0.972	0.917	0.537	D	c	0.094	0.198	0.094	0.162	0.706	0.609	0	4.11	0.472	6.164	0.715	0.709	0.301	1.000	0.715	1.000	0.888	15.272	0.733	Peptidase M1, membrane alanine aminopeptidase, N-terminal	.	.	0.5	.	56	chr17	45623336	chr17:45623336	C	T	.	PASS	AN=0;DP=56	GT	0/1
chr17	60563163	60563163	C	T	intronic	TLK2	.	.	.	0.999999806	1.94E-07	9.60E-18	.	0.36654	0.09988	-0.271755481	34.31823543	14.64528	0.52777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	95	chr17	60563163	chr17:60563163	C	T	60	PASS	AN=2;DP=95	GT	0/1
chr17	64500758	64500758	G	A	intronic	PRKCA	.	.	.	0.952135908	0.047864044	4.76E-08	.	0.81012	0.85579	-0.334253673	30.70299599	22.99218	0.76666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	24	chr17	64500758	chr17:64500758	G	A	.	PASS	AN=0;DP=24	GT	0/1
chr17	66972250	66972250	A	T	intronic	ABCA9	.	.	.	1.28E-26	0.089815749	0.910184251	.	0.07193	.	-0.001957219	53.73319179	5531.81651	15.36212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	13	chr17	66972250	chr17:66972250	A	T	82	PASS	AN=2;DP=13	GT	1/0
chr17	79507107	79507108	CG	-	UTR3	FAAP100	NM_025161:c.*738_*737delCG	.	.	.	.	.	.	0.14739	0.16001	0.363735434	74.71101675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	55	chr17	79507106	chr17:79507106	CCG	C	44	PASS	AN=2;DP=55	GT	0/1
chr18	34415357	34415357	-	T	intronic	KIAA1328	.	.	.	6.07E-05	0.894567113	0.105372162	.	0.32449	.	0.040529541	57.15380986	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	26	chr18	34415357	chr18:34415357	C	CT	50	PASS	AN=2;DP=26	GT	0/1
chr18	59878413	59878413	A	G	exonic	KIAA1468	.	nonsynonymous SNV	KIAA1468:NM_001346229:exon2:c.A554G:p.D185G,KIAA1468:NM_001346230:exon2:c.A554G:p.D185G,KIAA1468:NM_001346231:exon2:c.A554G:p.D185G,KIAA1468:NM_001346232:exon2:c.A554G:p.D185G,KIAA1468:NM_001346233:exon2:c.A554G:p.D185G,KIAA1468:NM_001346234:exon2:c.A554G:p.D185G,KIAA1468:NM_020854:exon2:c.A554G:p.D185G	0.99999956	4.40E-07	2.89E-18	.	0.18204	0.12098	-1.285933373	5.083746167	74.67048	1.80768	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.41	0.699	M	0.86	0.468	T	-5.46	0.855	D	0.91	0.900	-0.408	0.718	T	0.316	0.686	T	0.148	0.831	D	6.326	0.874	29.3	0.999	0.940	0.987	0.851	D	c	0.778	0.744	1.000	0.747	0.706	0.609	0	5.21	0.719	8.718	0.911	1.199	0.960	1.000	0.715	0.999	0.750	15.078	0.716	.	.	.	0.5	92	101	chr18	59878413	chr18:59878413	A	G	92	PASS	AN=2;DP=101	GT	0/1
chr18	60015409	60015409	G	A	exonic	TNFRSF11A	.	synonymous SNV	TNFRSF11A:NM_001270949:exon2:c.G84A:p.L28L,TNFRSF11A:NM_001270950:exon2:c.G84A:p.L28L,TNFRSF11A:NM_001270951:exon2:c.G84A:p.L28L,TNFRSF11A:NM_001278268:exon2:c.G84A:p.L28L,TNFRSF11A:NM_003839:exon2:c.G84A:p.L28L	0.879917354	0.120022306	6.03E-05	DISEASE: Paget disease of bone 2, early-onset (PDB2) [MIM:602080]: A form of Paget disease, a disorder of bone remodeling characterized by increased bone turnover affecting one or more sites throughout the skeleton, primarily the axial skeleton. Osteoclastic overactivity followed by compensatory osteoblastic activity leads to a structurally disorganized mosaic of bone (woven bone), which is mechanically weaker, larger, less compact, more vascular, and more susceptible to fracture than normal adult lamellar bone. {ECO:0000269|PubMed:10615125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteopetrosis, autosomal recessive 7 (OPTB7) [MIM:612301]: A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB7 is characterized by paucity of osteoclasts, suggesting a molecular defect in osteoclast development. OPTB7 is associated with hypogammaglobulinemia. {ECO:0000269|PubMed:18606301}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.0838	.	0.665103516	84.6131163	577.42674	4.87253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	chr18	60015409	chr18:60015409	G	A	.	PASS	AN=0;DP=32	GT	0/1
chr19	4472360	4472360	T	C	exonic	HDGFL2	.	nonsynonymous SNV	HDGFL2:NM_001001520:exon1:c.T13C:p.F5L,HDGFL2:NM_032631:exon1:c.T13C:p.F5L	.	.	.	.	.	.	.	.	.	.	.	.	.	0.41	0.388	B	0.241	0.408	B	0.000	0.629	N	0.995	0.423	D	1.26	0.320	L	.	.	.	.	.	.	0.231	0.453	-0.657	0.624	T	0.238	0.606	T	0.940	0.996	D	3.169	0.440	22.7	0.992	0.537	0.767	0.373	D	c	-0.128	-0.108	1.000	0.747	0.726	0.872	0	3.22	0.359	3.883	0.556	0.866	0.377	1.000	0.715	0.984	0.507	10.171	0.419	PWWP domain	.	.	0.5	68	119	chr19	4472360	chr19:4472360	T	C	68	PASS	AN=2;DP=119	GT	0/1
chr19	7604754	7604754	G	A	intronic	PNPLA6	.	.	.	1.59E-08	0.999981666	1.83E-05	DISEASE: Spastic paraplegia 39, autosomal recessive (SPG39) [MIM:612020]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG39 is associated with a motor axonopathy affecting upper and lower limbs and resulting in progressive wasting of distal upper and lower extremity muscles. {ECO:0000269|PubMed:18313024, ECO:0000269|PubMed:24355708}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Boucher-Neuhauser syndrome (BNHS) [MIM:215470]: An autosomal recessive disorder characterized by spinocerebellar ataxia, hypogonadotropic hypogonadism, and visual impairment due to chorioretinal dystrophy. The age at onset is variable, but most patients develop 1 or more symptoms in the first decade of life. Chorioretinal dystrophy may not always be present. {ECO:0000269|PubMed:24355708, ECO:0000269|PubMed:25033069}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Laurence-Moon syndrome (LNMS) [MIM:245800]: An autosomal recessive syndrome characterized by progressive spinocerebellar degeneration, spastic paraplegia, mental retardation, hypogonadism, dwarfism, and chorioretinopathy. Trichomegaly is absent. {ECO:0000269|PubMed:25480986}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Oliver-McFarlane syndrome (OMCS) [MIM:275400]: A rare autosomal recessive, congenital syndrome characterized by trichomegaly, severe chorioretinal atrophy and multiple pituitary hormone deficiencies. It results in intellectual impairment and dwarfism, if untreated. Clinical features include hypogonadotropic hypogonadism during puberty, pigmentary retinal degeneration, ataxia, spastic paraplegia, and peripheral neuropathy. {ECO:0000269|PubMed:25480986}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1035	0.15862	-1.142761145	6.375324369	1325.61906	6.84406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	chr19	7604754	chr19:7604754	G	A	.	PASS	AN=0;DP=43	GT	0/1
chr19	8962341	8962341	C	T	intronic	MUC16	.	.	.	.	.	.	.	0.05884	.	29.75317221	100	23894.83454	31.77381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	18	chr19	8962341	chr19:8962341	C	T	.	PASS	AN=0;DP=18	GT	0/1
chr19	12186761	12186761	A	G	exonic	ZNF844	.	nonsynonymous SNV	ZNF844:NM_001136501:exon4:c.A826G:p.T276A	1.01E-05	0.341425777	0.658564161	.	.	.	2.81877582	99.05638122	4160.71334	12.81024	0.066	0.361	T	0.363	0.322	B	0.114	0.302	B	.	.	.	0.993	0.588	P	2.02	0.555	M	1.73	0.264	T	-4.1	0.749	D	0.054	0.036	-1.012	0.262	T	0.000	0.000	T	.	.	.	2.136	0.318	17.09	0.951	0.255	0.000	0.000	N	c	-0.661	-0.780	0.001	0.082	0.776	0.995	0	1.45	0.216	3.402	0.521	0.672	0.294	0.703	0.284	0.010	0.111	6.394	0.207	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	ENSG00000214189.4|ENSG00000223547.5	Skin_Not_Sun_Exposed_Suprapubic|Thyroid	0.5	51	39	chr19	12186761	chr19:12186761	A	G	51	PASS	AN=2;DP=39	GT	0/1
chr19	35761963	35761963	-	T	intronic	USF2	.	.	.	0.992520444	0.00747812	1.44E-06	.	0.26523	0.33317	.	.	1586.84065	7.37078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	42	chr19	35761963	chr19:35761963	C	CT	50	PASS	AN=2;DP=42	GT	0/1
chr19	39978801	39978801	C	G	exonic	TIMM50	.	nonsynonymous SNV	TIMM50:NM_001329559:exon8:c.C458G:p.P153R,TIMM50:NM_001001563:exon9:c.C1106G:p.P369R	0.442656937	0.557064432	0.000278631	.	0.15447	0.10784	-0.045835247	50.34206181	685.25632	5.2276	0.236	0.179	T	0.002	0.156	B	0.005	0.121	B	0.001	0.409	D	0.795	0.344	D	0.015	0.080	N	2.23	0.181	T	3.42	0.001	N	0.227	0.278	-1.018	0.242	T	0.024	0.101	T	0.005	0.137	T	2.418	0.352	18.94	0.225	0.009	0.912	0.527	D	c	-0.128	0.081	0.857	0.251	0.707	0.730	0	4.96	0.650	2.818	0.475	0.852	0.362	0.999	0.424	0.997	0.653	10.696	0.449	FCP1 homology domain|HAD-like domain	.	.	0.5	118	134	chr19	39978801	chr19:39978801	C	G	118	PASS	AN=2;DP=134	GT	0/1
chr19	49316502	49316502	C	-	exonic	HSD17B14	.	frameshift deletion	HSD17B14:NM_016246:exon9:c.743delG:p.G248Vfs*32	0.001372525	0.963567036	0.035060439	.	0.21207	.	0.927856124	89.70276008	1316.53203	6.82371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	38	chr19	49316501	chr19:49316501	AC	A	45	PASS	AN=2;DP=38	GT	0/1
chr19	49606750	49606750	C	-	intronic	SNRNP70	.	.	.	0.993095086	0.006904675	2.39E-07	.	0.54826	0.24974	.	.	34.51837	1.05414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	91	chr19	49606749	chr19:49606749	TC	T	80	PASS	AN=2;DP=91	GT	0/1
chr19	54545085	54545085	A	-	intronic	VSTM1	.	.	.	4.39E-09	0.057039085	0.94296091	.	0.04548	.	0.084621747	60.31493277	1238.62841	6.64471	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	17	chr19	54545084	chr19:54545084	GA	G	54	PASS	AN=2;DP=17	GT	0/1
chr19	54649671	54649671	T	-	exonic	CNOT3	.	frameshift deletion	CNOT3:NM_014516:exon9:c.729delT:p.S245Afs*89	0.999967222	3.28E-05	2.56E-12	.	0.73088	0.10155	-0.598810865	18.13517339	98.27185	2.1432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	56	chr19	54649670	chr19:54649670	CT	C	45	PASS	AN=2;DP=56	GT	0/1
chr19	55602970	55602970	A	C	intronic	PPP1R12C	.	.	.	0.462120927	0.537869226	9.85E-06	.	0.29098	0.10482	-1.03794674	7.832035858	344.728	3.93807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	chr19	55602970	chr19:55602970	A	C	.	PASS	AN=0;DP=51	GT	0/1
chr19	58118572	58118572	A	G	exonic	ZNF530	.	nonsynonymous SNV	ZNF530:NM_020880:exon3:c.A1679G:p.N560S,ZNF530:NM_001321981:exon4:c.A1580G:p.N527S	1.74E-10	0.114407016	0.885592984	.	0.08489	.	1.820761234	97.009908	298.54254	3.68443	1.0	0.010	T	0.006	0.126	B	0.002	0.063	B	.	.	.	1	0.090	N	-1.34	0.007	N	3.21	0.071	T	2.18	0.003	N	0.01	0.001	-0.935	0.434	T	0.004	0.013	T	0.001	0.011	T	-2.277	0.005	0.001	0.157	0.004	0.041	0.094	N	c	-1.774	-1.775	0.003	0.100	0.563	0.310	0	-2.9	0.053	-2.862	0.008	-1.267	0.014	0.000	0.063	0.000	0.016	2.216	0.037	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	91	135	chr19	58118572	chr19:58118572	A	G	91	PASS	AN=2;DP=135	GT	0/1
chr20	32972827	32972827	T	-	intronic	ITCH	.	.	.	0.999990177	9.82E-06	5.57E-15	DISEASE: Autoimmune disease, multisystem, with facial dysmorphism (ADMFD) [MIM:613385]: A disorder characterized by organomegaly, failure to thrive, developmental delay, dysmorphic features and autoimmune inflammatory cell infiltration of the lungs, liver and gut. {ECO:0000269|PubMed:20170897}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.59377	0.08471	-1.089312628	7.047652748	40.17092	1.18051	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	43	chr20	32972826	chr20:32972826	AT	A	59	PASS	AN=2;DP=43	GT	0/1
chr20	56941976	56941976	A	-	UTR3	RAB22A	NM_020673:c.*7217delA	.	.	0.685129848	0.313970859	0.000899293	.	0.13239	0.12253	-0.207437529	38.2814343	9.37183	0.34486	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	11	chr20	56941975	chr20:56941975	CA	C	53	PASS	AN=2;DP=11	GT	0/1
chr21	30433909	30433909	A	-	intronic	CCT8	.	.	.	0.98279276	0.017206786	4.54E-07	.	0.89566	0.47642	-0.246069119	36.06982779	254.13959	3.42911	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	17	chr21	30433908	chr21:30433908	CA	C	44	PASS	AN=2;DP=17	GT	0/1
chr21	41741065	41741142	CTCCGGTGTATCGATGCCGCGTGATGCAGCGGTAGTTATACAATCCATCTTCATTCTGTACATCTTTAATATACAAGG	-	exonic	DSCAM	.	nonframeshift deletion	DSCAM:NM_001271534:exon4:c.539_616del:p.A180_G205del,DSCAM:NM_001389:exon4:c.539_616del:p.A180_G205del	1	1.62E-10	1.24E-26	.	0.15662	0.10818	-3.289804051	0.430526067	213.32232	3.15158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	11	chr21	41741064	chr21:41741064	TCTCCGGTGTATCGATGCCGCGTGATGCAGCGGTAGTTATACAATCCATCTTCATTCTGTACATCTTTAATATACAAGG	T	41	PASS	AN=2;DP=11	GT	0/1
chr22	20104472	20104472	C	T	UTR5	TRMT2A	NM_182984:c.-43G>A;NM_022727:c.-43G>A;NM_001257994:c.-43G>A;NM_001331039:c.-43G>A	.	.	1.31E-05	0.954123928	0.045863013	.	.	0.10123	-0.949752638	9.32413305	192.14774	3.00453	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	73	chr22	20104472	chr22:20104472	C	T	58	PASS	AN=2;DP=73	GT	0/1
chr22	37707028	37707028	G	-	splicing	CYTH4	NM_001318024:exon10:c.638-1G>-;NM_013385:exon10:c.809-1G>-	.	.	0.572494882	0.42740411	0.000101009	.	0.24327	0.12192	0.086440867	60.47416844	260.30767	3.46595	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	60	chr22	37707027	chr22:37707027	AG	A	44	PASS	AN=2;DP=60	GT	0/1
chr22	37768968	37768971	GTGC	-	UTR3	ELFN2	NM_052906:c.*144_*141delGCAC	.	.	0.849015287	0.150440504	0.000544209	.	0.18208	.	-1.835411529	2.081858929	137.02578	2.54496	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	71	chr22	37768967	chr22:37768967	TGTGC	T	42	PASS	AN=2;DP=71	GT	0/1
chr22	44276728	44276728	G	A	exonic	PNPLA5	.	stopgain	PNPLA5:NM_001177675:exon7:c.C895T:p.Q299X,PNPLA5:NM_138814:exon9:c.C1237T:p.Q413X	9.38E-07	0.317699047	0.682300015	.	0.17953	0.09445	0.576916344	82.25406936	1541.98025	7.28556	.	.	.	.	.	.	.	.	.	.	.	.	0.810	0.346	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	8.992	0.961	35	0.967	0.301	0.113	0.163	N	c	0.037	-0.331	0.035	0.142	0.615	0.352	0	2.1	0.261	1.248	0.322	1.048	0.713	0.057	0.215	0.008	0.104	8.910	0.345	.	.	.	0.5	.	65	chr22	44276728	chr22:44276728	G	A	.	PASS	AN=0;DP=65	GT	0/1
chr22	45728562	45728562	C	T	exonic	FAM118A	.	nonsynonymous SNV	FAM118A:NM_001349915:exon5:c.C686T:p.A229V,FAM118A:NM_001349913:exon6:c.C908T:p.A303V,FAM118A:NM_001349914:exon6:c.C911T:p.A304V,FAM118A:NM_017911:exon6:c.C908T:p.A303V,FAM118A:NM_001104595:exon7:c.C908T:p.A303V,FAM118A:NM_001349916:exon8:c.C950T:p.A317V	0.591868565	0.406055484	0.002075951	.	0.10583	0.09201	-0.001743238	53.85114414	52.56756	1.43555	0.103	0.301	T	0.518	0.356	P	0.129	0.312	B	0.020	0.270	N	0.978	0.394	D	0.975	0.246	L	1.49	0.315	T	-0.28	0.116	N	0.492	0.573	-1.101	0.040	T	0.050	0.213	T	0.006	0.157	T	2.171	0.322	17.32	0.997	0.785	0.906	0.516	D	c	-0.143	-0.043	1.000	0.480	0.707	0.730	0	4.7	0.586	4.701	0.613	0.852	0.362	0.970	0.340	1.000	0.888	16.225	0.820	.	.	.	0.5	50	51	chr22	45728562	chr22:45728562	C	T	50	PASS	AN=2;DP=51	GT	0/1
chr22	46447677	46447756	GAGCCCTGGGTTTGGGCTGAGCGCGGTAGCTCATACCTGTAATTCCAGCACATTGGGAGGCCGAGGCAGGAAGATTGCAT	-	exonic	PRR34	.	frameshift deletion	PRR34:NM_018280:exon2:c.368_447del:p.H123Lfs*35	.	.	.	.	0.07675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	29	chr22	46447676	chr22:46447676	AGAGCCCTGGGTTTGGGCTGAGCGCGGTAGCTCATACCTGTAATTCCAGCACATTGGGAGGCCGAGGCAGGAAGATTGCAT	A	50	PASS	AN=2;DP=29	GT	0/1
chrX	38240577	38240577	-	T	intronic	OTC	.	.	.	0.9810179	0.01896801	1.41E-05	DISEASE: Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]: An X-linked disorder of the urea cycle which causes a form of hyperammonemia. Mutations with no residual enzyme activity are always expressed in hemizygote males by a very severe neonatal hyperammonemic coma that generally proves to be fatal. Heterozygous females are either asymptomatic or express orotic aciduria spontaneously or after protein intake. The disorder is treatable with supplemental dietary arginine and low protein diet. The arbitrary classification of patients into the 'neonatal' group (clinical hyperammonemia in the first few days of life) and 'late' onset (clinical presentation after the neonatal period) has been used to differentiate severe from mild forms. {ECO:0000269|PubMed:10070627, ECO:0000269|PubMed:10502831, ECO:0000269|PubMed:10737985, ECO:0000269|PubMed:11793483, ECO:0000269|PubMed:1480464, ECO:0000269|PubMed:1671317, ECO:0000269|PubMed:1721894, ECO:0000269|PubMed:2347583, ECO:0000269|PubMed:2474822, ECO:0000269|PubMed:3170748, ECO:0000269|PubMed:7474905, ECO:0000269|PubMed:7951259, ECO:0000269|PubMed:8019569, ECO:0000269|PubMed:8081373, ECO:0000269|PubMed:8081398, ECO:0000269|PubMed:8099056, ECO:0000269|PubMed:8530002, ECO:0000269|PubMed:8807340, ECO:0000269|PubMed:8830175, ECO:0000269|PubMed:8956038, ECO:0000269|PubMed:8956045, ECO:0000269|PubMed:9143919, ECO:0000269|PubMed:9266388, ECO:0000269|PubMed:9286441, ECO:0000269|PubMed:9452024, ECO:0000269|PubMed:9452049, ECO:0000269|PubMed:9452065, ECO:0000269|Ref.32, ECO:0000269|Ref.43}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.22278	0.85665	0.082802743	60.09082331	1072.1412	6.27812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	70	chrX	38240577	chrX:38240577	C	CT	52	PASS	AN=2;DP=70	GT	0/1
chrX	40962052	40962052	T	-	intronic	USP9X	.	.	.	1	2.36E-11	2.78E-27	.	0.58131	0.10304	-1.618506764	2.925218212	35.92323	1.07855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	51	chrX	40962051	chrX:40962051	CT	C	73	PASS	AN=2;DP=51	GT	0/1
chrX	63409795	63409795	G	A	exonic	AMER1	.	synonymous SNV	AMER1:NM_152424:exon2:c.C3372T:p.Y1124Y	0.953441253	0.046553393	5.35E-06	.	.	0.08523	-0.394936437	27.02878037	88.95926	2.02444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	chrX	63409795	chrX:63409795	G	A	.	PASS	AN=0;DP=45	GT	0/1
chrX	71372288	71372288	G	A	intronic	FLJ44635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	chrX	71372288	chrX:71372288	G	A	.	PASS	AN=0;DP=49	GT	0/1
chrX	96171455	96171455	C	T	exonic	DIAPH2	.	synonymous SNV	DIAPH2:NM_006729:exon8:c.C751T:p.L251L,DIAPH2:NM_007309:exon8:c.C751T:p.L251L	0.9991191	0.0008809	6.44E-11	DISEASE: Premature ovarian failure 2A (POF2A) [MIM:300511]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:9497258}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.56881	0.27299	-0.999300439	8.368719038	38.85136	1.15117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	94	chrX	96171455	chrX:96171455	C	T	59	PASS	AN=2;DP=94	GT	0/1
chrX	96171478	96171479	AC	-	exonic	DIAPH2	.	frameshift deletion	DIAPH2:NM_006729:exon8:c.774_775del:p.L258Ffs*6,DIAPH2:NM_007309:exon8:c.774_775del:p.L258Ffs*6	0.9991191	0.0008809	6.44E-11	DISEASE: Premature ovarian failure 2A (POF2A) [MIM:300511]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:9497258}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.56881	0.27299	-0.999300439	8.368719038	38.85136	1.15117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	99	chrX	96171477	chrX:96171477	TAC	T	58	PASS	AN=2;DP=99	GT	0/1
chrX	118722385	118722385	G	A	UTR3	NKRF	NM_017544:c.*930C>T;NM_001173487:c.*930C>T;NM_001173488:c.*930C>T	.	.	0.955812168	0.044073795	0.000114037	.	0.48621	0.20971	-0.538132194	20.26421326	17.80669	0.62232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	chrX	118722385	chrX:118722385	G	A	.	PASS	AN=0;DP=26	GT	0/1
chrX	118722401	118722401	T	A	UTR3	NKRF	NM_017544:c.*914A>T;NM_001173487:c.*914A>T;NM_001173488:c.*914A>T	.	.	0.955812168	0.044073795	0.000114037	.	0.48621	0.20971	-0.538132194	20.26421326	17.80669	0.62232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	49	chrX	118722401	chrX:118722401	T	A	58	PASS	AN=2;DP=49	GT	0/1
chrX	129354353	129354354	TT	-	exonic	ZNF280C	.	frameshift deletion	ZNF280C:NM_017666:exon13:c.1496_1497del:p.K499Rfs*50	0.992273042	0.007726643	3.15E-07	.	0.1424	.	-0.492218069	22.35786742	14.15249	0.5125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.32	27	chrX	129354352	chrX:129354352	CTT	C	11.32	PASS	AN=0;DP=27	GT	0/1
chrX	134556298	134556300	CGG	-	UTR3	SMIM10L2A	NM_203306:c.*5_*7delCGG	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	71	chrX	134556297	chrX:134556297	CCGG	C	44	PASS	AN=2;DP=71	GT	0/1
